Cirrhosis of liver, NAS

CHIRHEP_NAS

Cirrhosis of liver is when scar tissue replaces healthy liver tissue

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps	FinnGen
Phenotype data	519972
1. Apply sex-specific rule None	519972
2. Check conditions None	519972
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — K74.6 Cause of death: ICD-10 — K74.6 2 out of 7 registries used, show all original rules.	2025
4. Check minimum number of events None	2025
5. Include endpoints None	2025
6. Filter based on genotype QC (FinnGen only)	1973

Control definitions (FinnGen only)

Control exclude: CIRRHOSIS_BROAD

Extra metadata

First used in FinnGen datafreeze: DF2
Parent code in ICD-10: K74
Name in latin: Cirrhosis hepatis alia sive non specificata

NAME	CHIRHEP_NAS
CONTROL_EXCLUDE	CIRRHOSIS_BROAD
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	K746
HD_ICD_9	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
HD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	K746
COD_ICD_9	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
COD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Cirrhosis of liver, NAS based on the number of shared cases.

Similar with more cases:

Similar with less cases:

None

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	15092	5951	8918
Only index persons	11422	4569	6853
Unadjusted period prevalence (%)
Whole population	0.22	0.17	0.25
Only index persons	0.22	0.17	0.26
Median age at first event (years)
Whole population	66.47	68.55	65.01
Only index persons	66.10	67.59	65.10

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	1973	764	1209
Unadjusted period prevalence (%)	0.44	0.27	0.55
Median age at first event (years)	67.35	66.81	67.70

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
2024: Matched controls
20240

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

A06AD11

ATC

lactulose; oral

6.0

318.1

781

1922

K70.3

ICD-10 Finland

Alcoholic cirrhosis of liver

+∞

307.7

542

C03DA01

ATC

spironolactone; oral

16.6

307.7

1159

1513

JJ2AT

NOMESCO Finland

Biopsy of liver with ultrasound guidance

25.6

307.7

361

170

R18

ICD-10 Finland

Ascites

76.0

307.7

598

111

C03CA01

ATC

furosemide; systemic

7.1

307.7

1380

4671

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

10.2

307.7

708

1011

I85.9

ICD-10 Finland

Oesophageal varices without bleeding

7454.7

307.7

559

K74.6

ICD-10 Finland

Other and unspecified cirrhosis of liver

4503599627370496.0

307.7

2023

JA3AT

NOMESCO Finland

Cathetrisation of abdominal cavity with ultrasound guidance

42.6

307.7

379

109

C22.0

ICD-10 Finland

Malignant neoplasm: Liver cell carcinoma

83.1

307.7

261

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

7.0

307.7

763

1604

K76.0

ICD-10 Finland

Fatty (change of) liver, not elsewhere classified

17.1

307.7

285

192

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

9.5

307.7

1451

4275

JA2AT

NOMESCO Finland

Abdominal puncture with ultrasound guidance

34.8

283.3

181

K72.9

ICD-10 Finland

Hepatic failure, unspecified

74.3

268.7

145

JJ1LE

NOMESCO Finland

Ultrasound elastography of liver

35.1

264.1

168

103

Kela drug reimbursment

Diabetes, insulin-treated

4.4

241.2

1082

4163

A10AE04

ATC

insulin glargine; parenteral

5.7

234.8

532

1187

K76.9

ICD-10 Finland

Liver disease, unspecified

22.8

229.4

170

E11.9

ICD-10 Finland

Type 2 diabetes mellitus, without complications

4.3

226.2

992

3717

JCA22

NOMESCO Finland

Endoscopic ligature of oesophageal varices

492.5

225.6

221

8170/3-C22.0

ICD-O-3

Hepatocellular carcinoma, NOS, of liver

58.4

215.3

121

A05AA02

ATC

ursodeoxycholic acid; oral

22.3

210.3

157

K92.0

ICD-10 Finland

Haematemesis

12.1

204.3

214

196

C07AG02

ATC

carvedilol; oral

6.3

200.1

379

709

B18.2

ICD-10 Finland

Chronic viral hepatitis C

30.1

195.4

130

I85.0

ICD-10 Finland

Oesophageal varices with bleeding

+∞

191.8

181

215

Kela drug reimbursment

Diabetes, non-insulin-treated

3.8

187.2

936

3737

D64.9

ICD-10 Finland

Anaemia, unspecified

4.8

185.6

523

1382

D97

ICPC

Liver disease NOS

53.2

185.2

106

A10AB05

ATC

insulin aspart; parenteral

5.6

183.3

398

843

JN3DE

NOMESCO Finland

Abdominal extensive ultrasoudn examination with blood flow measurements after transplantation

61.2

177.7

A10BA02

ATC

metformin; oral

3.6

174.6

1020

4457

127

Kela drug reimbursment

Transplant complication

15.1

173.1

156

111

T90

ICPC

Diabetes non-insulin dependent

3.6

168.1

894

3662

E11.8

ICD-10 Finland

Type 2 diabetes mellitus, with unspecified complications

4.4

166.0

516

1461

D50.9

ICD-10 Finland

Iron deficiency anaemia, unspecified

5.4

164.5

374

821

A10BH01

ATC

sitagliptin; oral

4.5

157.9

460

1236

A07AA11

ATC

rifaximin; oral

328.6

150.9

151

L04AD02

ATC

tacrolimus; systemic

20.4

147.8

114

L04AA06

ATC

mycophenolic acid; systemic

11.9

147.8

154

139

K92.1

ICD-10 Finland

Melaena

5.7

146.7

301

600

D69.6

ICD-10 Finland

Thrombocytopenia, unspecified

11.0

144.8

159

155

C07AA05

ATC

propranolol; systemic

3.6

144.6

625

2208

JN1CG

NOMESCO Finland

Extensive MRI examination of upper part of abdomen with high intensity magnet

9.8

144.5

174

193

Z94.4

ICD-10 Finland

Liver transplant status

177.3

142.5

148

JJC00

NOMESCO Finland

Allogenic transplantation of liver

479.1

136.9

135

D50.0

ICD-10 Finland

Iron deficiency anaemia secondary to blood loss (chronic)

7.8

135.7

198

278

K74.3

ICD-10 Finland

Primary biliary cirrhosis

32.4

134.3

K72.0

ICD-10 Finland

Acute and subacute hepatic failure

51.2

128.3

D37.6

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Liver, gallbladder and bile ducts

11.5

128.1

136

126

TPH15

NOMESCO Finland

Insertion of central venous catheter through external or internal jugular vein

4.9

127.6

313

726

JN1DG

NOMESCO Finland

Very extensive MRI examination of upper part of abdomen with high intensity magnet

10.1

125.6

146

154

JN3AD

NOMESCO Finland

Abdominal CT examination

3.8

118.5

441

1393

A10AC01

ATC

insulin (human); parenteral

4.4

111.0

316

821

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

3.1

110.0

613

2477

N17.9

ICD-10 Finland

Acute renal failure, unspecified

5.5

108.0

226

455

E11.7

ICD-10 Finland

Type 2 diabetes mellitus, with multiple complications

4.7

107.4

271

640

TK800

NOMESCO Finland

Hemodialysis

8.0

104.0

146

195

I81

ICD-10 Finland

Portal vein thrombosis

31.5

102.6

K72.1

ICD-10 Finland

Chronic hepatic failure

271.4

101.8

103

285

Kela drug reimbursment

Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)

4.6

100.9

265

645

A10AE05

ATC

insulin detemir; parenteral

4.9

100.0

242

551

K70.4

ICD-10 Finland

Alcoholic hepatic failure

1017.0

100.0

K73.2

ICD-10 Finland

Chronic active hepatitis, not elsewhere classified

49.7

99.9

WW500

NOMESCO Finland

Blood transfusion

5.4

97.4

205

414

198

Kela drug reimbursment

Sorafenib

45.1

96.1

K76.7

ICD-10 Finland

Hepatorenal syndrome

973.0

95.8

I50.9

ICD-10 Finland

Heart failure, unspecified

3.1

94.9

499

1931

JN3CD

NOMESCO Finland

Abdominal CT examination both without and with contrast

5.8

94.6

182

338

A10BB12

ATC

glimepiride; oral

3.9

93.4

304

867

A41.0

ICD-10 Finland

Sepsis due to Staphylococcus aureus

7.9

93.2

132

178

JJ9AE

NOMESCO Finland

Ultrasound examination of liver transplant

327.7

92.7

R17

ICD-10 Finland

Hyperbilirubinaemia, with or without jaundice, not elsewhere classified

10.1

92.0

106

110

346

Kela drug reimbursment

Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)

4.5

91.6

241

586

UJF32

NOMESCO Finland

Coloscopy

2.6

88.9

775

3890

160

Kela drug reimbursment

exenatide

7.4

88.8

133

191

G93.4

ICD-10 Finland

Encephalopathy, unspecified

52.3

88.7

K73.80

ICD-10 Finland

Non-alcoholic fatty liver (NASH, Non Alcoholic Steatohepatitis)

25.6

88.5

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

2.8

87.8

581

2538

E11

ICD-10 Finland

Type 2 diabetes mellitus

2.9

87.3

538

2263

F10.1

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Harmful use

4.1

86.8

262

706

GD1AA

NOMESCO Finland

Thorax X-ray examination

2.5

86.4

1232

7736

A46

ICD-10 Finland

Erysipelas

2.9

86.0

493

1992

JDW98

NOMESCO Finland

Other transluminal endoscopic operation on stomach or duodenum

9.3

85.8

105

118

E66.00

ICD-10 Finland

Metabolic syndrome

4.4

85.0

231

575

A41.5

ICD-10 Finland

Sepsis due to other Gram-negative organisms

5.5

84.2

172

337

K74.0

ICD-10 Finland

Hepatic fibrosis

+∞

83.9

K29.6

ICD-10 Finland

Other gastritis

10.8

82.0

K75.9

ICD-10 Finland

Inflammatory liver disease, unspecified

12.2

80.2

N02AX02

ATC

tramadol; systemic, rectal

2.4

78.8

1117

6889

K70.1

ICD-10 Finland

Alcoholic hepatitis

+∞

78.7

Z51.5

ICD-10 Finland

Palliative care

3.4

78.4

314

1023

TJA10

NOMESCO Finland

Laparocentesis

32.0

76.9

A49.9

ICD-10 Finland

Bacterial infection, unspecified

3.0

73.7

390

1496

C22.9

ICD-10 Finland

Malignant neoplasm: Liver, unspecified

20.2

71.4

A02BC02

ATC

pantoprazole; systemic

2.6

71.3

1564

11463

SPAT1262

SPAT

Handing over of treatment supplies

2.6

70.5

533

2455

L04AD01

ATC

ciclosporin; systemic

7.7

70.3

101

138

E87.5

ICD-10 Finland

Hyperkalaemia

7.2

69.4

105

152

A41.9

ICD-10 Finland

Sepsis, unspecified

4.8

69.1

163

361

TPH04

NOMESCO Finland

Cathetrisation of vein

2.4

68.1

624

3135

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

3.0

68.1

343

1276

JN4AD

NOMESCO Finland

Body CT examination

3.0

67.4

359

1378

I50.0

ICD-10 Finland

Congestive heart failure

3.4

67.0

273

895

E11.6

ICD-10 Finland

Type 2 diabetes mellitus, with other specified complications

6.3

65.6

114

191

JN3BD

NOMESCO Finland

Extensive abdominal CT

3.0

64.8

324

1198

K83.0

ICD-10 Finland

Cholangitis

7.7

64.8

124

K29.7

ICD-10 Finland

Gastritis, unspecified

4.8

64.1

153

342

K73.9

ICD-10 Finland

Chronic hepatitis, unspecified

20.9

62.0

A10BH05

ATC

linagliptin; oral

3.7

59.3

202

588

A10BJ02

ATC

liraglutide; parenteral

5.3

59.1

124

248

A10BX07

ATC

[U] liraglutide

7.6

57.9

113

N18.9

ICD-10 Finland

Chronic kidney disease, unspecified

3.4

57.4

227

728

8000/3-C22.0

ICD-O-3

Neoplasm, malignant of liver

125.7

57.1

177

Kela drug reimbursment

Insulin glargine 300 U / ml

6.3

56.6

160

M04AA01

ATC

allopurinol; systemic

2.5

56.6

430

1963

162

Kela drug reimbursment

liraglutide

7.9

55.0

205

Kela drug reimbursment

Chronic hypertension

2.1

55.0

748

4356

TPH07

NOMESCO Finland

Cathetrisation of artery

2.7

54.7

357

1512

WYA30

NOMESCO Finland

Treatment of a patient needing special arrangements

3.3

54.6

230

766

K92.2

ICD-10 Finland

Gastrointestinal haemorrhage, unspecified

4.7

53.8

129

289

A10BG03

ATC

pioglitazone; oral

5.0

53.5

120

254

JN4CD

NOMESCO Finland

Very extensive body CT

4.1

53.5

155

402

K70.9

ICD-10 Finland

Alcoholic liver disease, unspecified

278.3

53.4

UJF30

NOMESCO Finland

Ileoscopy through colon

2.8

53.4

303

1194

EBA15

NOMESCO Finland

Extraction of multiple teeth

4.0

52.9

158

419

K70.0

ICD-10 Finland

Alcoholic fatty liver

68.6

52.4

A10BD07

ATC

metformin and sitagliptin; systemic

3.8

52.4

170

478

K29.5

ICD-10 Finland

Chronic gastritis, unspecified

4.9

51.8

119

257

R50.9

ICD-10 Finland

Fever, unspecified

2.5

51.5

404

1864

A10BJ06

ATC

semaglutide; parenteral

3.7

50.9

173

502

R74.0

ICD-10 Finland

Elevation of levels of transaminase and lactic acid dehydrogenase [LDH]

6.8

50.8

124

R4110

NOMESCO Finland

Physiotherapy

2.1

50.7

684

3946

E11.00

ICD-10 Finland

Non-insulin dependent diabetes diabetic hypoglycaemic coma

4.4

49.2

130

314

N17.8

ICD-10 Finland

Other acute renal failure

7.4

48.5

J01MA02

ATC

ciprofloxacin; systemic

2.0

48.1

929

6067

N19

ICD-10 Finland

Unspecified kidney failure

3.9

47.8

146

393

L97

ICD-10 Finland

Ulcer of lower limb, not elsewhere classified

4.0

47.5

140

367

WX892

NOMESCO Finland

Monitored bed care

2.9

47.2

247

929

E11.2

ICD-10 Finland

Type 2 diabetes mellitus, with renal complications

4.0

46.8

140

371

XW000

NOMESCO Finland

Bone marrow biopsy

3.6

46.5

161

472

JJ5AT, ,

NOMESCO Finland

468.2

46.5

K76.6

ICD-10 Finland

Portal hypertension

+∞

46.0

JKE98

NOMESCO Finland

Other transduodenal endoscopic operation on bile duct or ampulla of Vater

6.2

45.8

131

N02AA05

ATC

oxycodone; systemic

2.2

45.7

495

2606

F10.25

ICD-10 Finland

Alcohol dependence continuous use

6.3

44.0

123

P15

ICPC

Chronic alcohol abuse

4.6

43.8

108

247

A10BX04

ATC

[U] exenatide

7.4

43.8

FM1AE

NOMESCO Finland

Standard cardiac ultrasound examination

2.1

43.6

513

2784

J90

ICD-10 Finland

Pleural effusion, not elsewhere classified

4.0

43.5

130

344

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

2.0

43.4

759

4748

JL5BG

NOMESCO Finland

MRI examinaiton of bile and pancreas ducts with high intesity magnet

4.9

43.1

202

E66.8

ICD-10 Finland

Other obesity

3.6

42.1

143

414

E66.01

ICD-10 Finland

Obesity due to excess calories

2.9

41.7

213

789

ZXE40

NOMESCO Finland

More than seven and less than nine hours

5.0

41.7

192

R60.0

ICD-10 Finland

Localized oedema

2.4

41.7

328

1505

A10BK01

ATC

dapagliflozin; oral

2.8

40.8

219

833

E11.4

ICD-10 Finland

Type 2 diabetes mellitus, with neurological complications

4.5

40.7

101

232

F10.20

ICD-10 Finland

Alcohol dependence currently independent

5.6

40.7

147

L04AX01

ATC

azathioprine; systemic

3.7

40.7

133

375

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

1.9

40.3

736

4645

K65.0

ICD-10 Finland

Acute peritonitis

7.8

40.0

ZX120

NOMESCO Finland

Intravenous

2.6

39.7

266

1131

XF400

NOMESCO Finland

ECG with 12 standard connections

2.2

39.7

429

2243

E87.1

ICD-10 Finland

Hypo-osmolality and hyponatraemia

3.4

39.7

147

450

E66.9

ICD-10 Finland

Obesity, unspecified

4.2

39.1

106

261

I86.4

ICD-10 Finland

Gastric varices

384.5

38.2

A28

ICPC

Limited function/disability NOS

2.1

37.7

441

2372

S97

ICPC

Chronic ulcer skin

2.9

37.5

193

717

GA4YT

NOMESCO Finland

Puncture of pleura with ultrasound guidance

3.7

37.5

125

357

UJF92

NOMESCO Finland

Capsular endoscopy

5.1

37.2

163

JL5AG

NOMESCO Finland

Simple MRI examinaiton of bile and pancreas ducts with high intesity magnet

8.6

36.6

J01FF01

ATC

clindamycin; systemic

1.9

36.2

625

3845

WX872

NOMESCO Finland

Intensive care

2.9

35.6

174

628

D12.6

ICD-10 Finland

Benign neoplasm: Colon, unspecified

2.9

35.3

176

642

SPAT1250

SPAT

Comprehensive monitoring of chronic illness

1.9

35.2

645

4038

K25.9

ICD-10 Finland

Gastric ulcer, Unspecified as acute or chronic, without haemorrhage or perforation

5.3

35.1

137

Z2446

NOMESCO Finland

Social worker

2.9

34.9

175

640

A08

ICPC

Swelling

3.1

34.8

157

541

A41.8

ICD-10 Finland

Other specified sepsis

4.9

34.8

165

R04.0

ICD-10 Finland

Epistaxis

2.6

34.6

222

922

JN1CD

NOMESCO Finland

Very extensive CT examination of upper part of abdomen

8.9

34.6

F10.24

ICD-10 Finland

Alcohol depence active use

5.8

34.5

114

SPAT1148

SPAT

Treatment of chronic ulcer or burn

2.1

33.9

355

1823

A10BJ05

ATC

dulaglutide; parenteral

4.8

33.8

169

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

2.1

33.7

364

1892

UJD02

NOMESCO Finland

Gastroscopy

3.1

33.7

150

513

Z04.8

ICD-10 Finland

Examination and observation for other specified reasons

2.3

33.6

302

1458

Z3231

NOMESCO Finland

Registered nurse

1.9

33.4

618

3868

PC2DT

NOMESCO Finland

Embolisation of lesion of liver

91.6

32.8

A10BK03

ATC

empagliflozin; oral

2.3

32.6

278

1312

B82

ICPC

Anaemia other/unspecified

3.9

32.5

261

PG1DE

NOMESCO Finland

Other extensive ultrasound examination of artery

3.0

32.4

147

508

K70.2

ICD-10 Finland

Alcoholic fibrosis and sclerosis of liver

+∞

32.4

R06.0

ICD-10 Finland

Dyspnoea

1.8

32.4

625

3958

WX002

NOMESCO Finland

Sedation and analgesia

2.0

32.3

468

2701

I50

ICD-10 Finland

Heart failure

3.7

31.7

102

284

C10AC01

ATC

colestyramine; oral

4.3

31.5

200

F10.29

ICD-10 Finland

Addiction caused by alcohol UNS

4.2

31.5

213

D64.8

ICD-10 Finland

Other specified anaemias

4.9

31.5

147

XF603

NOMESCO Finland

Direct intraarterial blood pressure measurement

3.3

31.5

122

384

R41.0

ICD-10 Finland

Disorientation, unspecified

3.6

31.4

105

300

E83.1

ICD-10 Finland

Disorders of iron metabolism

10.8

31.4

JCA32

NOMESCO Finland

Endoscopic injection in oesophagus

53.8

31.4

JN1BG

NOMESCO Finland

MRI examination of upper part of abodmen with high intensity magnet

6.4

31.3

A10AD05

ATC

insulin aspart; parenteral

4.6

31.2

164

K74.5

ICD-10 Finland

Biliary cirrhosis, unspecified

86.5

30.8

JFA15

NOMESCO Finland

Endoscopic polypectomy in colon

2.6

30.8

185

743

R60.9

ICD-10 Finland

Oedema, unspecified

2.9

30.7

153

557

M10.9

ICD-10 Finland

Gout, unspecified

2.5

30.7

212

911

K80.2

ICD-10 Finland

Calculus of gallbladder without cholecystitis

2.3

30.6

266

1264

ZXD05

NOMESCO Finland

Urgent procedure

1.8

30.5

645

4183

C07AB07

ATC

bisoprolol; oral

1.7

30.3

1116

8447

PC2ET

NOMESCO Finland

Extensive embolisation of lesion of liver

59.3

30.1

H02AB04

ATC

methylprednisolone; systemic

2.1

30.1

330

1719

JN4BD

NOMESCO Finland

Extensive body CT

2.2

30.0

279

1363

L28

ICPC

Limited function/disability (L)

2.0

30.0

420

2390

ZX108

NOMESCO Finland

Inhalation

7.9

29.8

AA1AD

NOMESCO Finland

CT of head and brain

1.8

29.8

640

4166

K75.4

ICD-10 Finland

Autoimmune hepatitis

35.2

29.7

L40.0

ICD-10 Finland

Psoriasis vulgaris

3.2

29.6

124

409

SPAT1088

SPAT

Blood transfusion

9.9

29.5

H02AB06

ATC

prednisolone; systemic

1.7

29.4

993

7323

WVA20

NOMESCO Finland

Medicine administration

3.9

29.1

235

JJA21

NOMESCO Finland

Laparoscopic biopsy of liver

67.0

29.0

E11.3

ICD-10 Finland

Type 2 diabetes mellitus, with ophthalmic complications

3.5

28.8

102

303

WX408

NOMESCO Finland

General anesthesy, balanced

1.8

28.5

576

3675

JAH01

NOMESCO Finland

Laparoscopy

3.4

28.4

103

311

J01MA12

ATC

levofloxacin; systemic

1.9

28.1

447

2646

R93.2

ICD-10 Finland

Abnormal findings on diagnostic imaging of liver and biliary tract

7.3

28.0

E66.0

ICD-10 Finland

Obesity due to excess calories

6.3

27.9

E14.9

ICD-10 Finland

Unspecified diabetes mellitus, without complications

4.8

27.9

134

TPH30

NOMESCO Finland

Insertion of central venous catheter through periferal vein

4.6

27.9

150

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

2.0

27.9

383

2160

B80

ICPC

Iron deficiency anaemia

4.3

27.8

171

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

2.1

27.7

284

1440

D50.8

ICD-10 Finland

Other iron deficiency anaemias

5.5

27.7

101

Z2221

NOMESCO Finland

Medical doctor

1.8

27.6

559

3562

UJD10, ,

SPAT

4.1

27.5

190

RS220, ,

NOMESCO Finland

6.0

27.4

138

Kela drug reimbursment

Severe anaemia associated with chronic renal failure

4.0

27.3

204

R94.5

ICD-10 Finland

Abnormal results of liver function studies

6.6

27.3

JCA20

NOMESCO Finland

Ligature of oesophageal varices

+∞

27.1

N18.8

ICD-10 Finland

Other chronic renal failure

3.7

26.9

243

K29.3

ICD-10 Finland

Chronic superficial gastritis

3.2

26.6

107

344

JJ6LT

NOMESCO Finland

Coagulation of focal hepatic lesion under ultrasound guidance

34.5

26.5

QDB10

NOMESCO Finland

Major dressing of wound of skin of lower limb

2.7

26.3

145

557

FM1EE

NOMESCO Finland

Extensive structural and functional ultrasound examination of heart

1.8

26.2

562

3633

D62

ICD-10 Finland

Acute posthaemorrhagic anaemia

6.2

25.9

L01XE05

ATC

[U] sorafenib

40.7

25.9

E87.6

ICD-10 Finland

Hypokalaemia

3.2

25.7

106

346

TJJ00

NOMESCO Finland

Percutaneous needle biopsy of liver

24.4

25.7

WZC10

NOMESCO Finland

Written specialist consultation based on a referral from a dentist or a physician

3.0

25.7

121

427

N05CF01

ATC

zopiclone; oral

1.7

25.7

683

4680

I35.0

ICD-10 Finland

Aortic (valve) stenosis

2.4

25.6

179

772

K29.0

ICD-10 Finland

Acute haemorrhagic gastritis

7.9

25.6

I85

ICD-10 Finland

Oesophageal varices

+∞

25.0

JDA52

NOMESCO Finland

Other endoscopic procedure using diathermy or heat in stomach or pylorus

30.5

25.0

V03AE01

ATC

polystyrene sulfonate; oral

5.1

24.9

107

N05CD07

ATC

temazepam; oral

2.0

24.8

286

1511

A10BB01

ATC

glibenclamide; oral

2.9

24.8

117

413

K42.9

ICD-10 Finland

Umbilical hernia without obstruction or gangrene

2.6

24.7

147

587

D05AX52

ATC

calcipotriol, combinations; topical

2.7

24.6

140

546

F10.31

ICD-10 Finland

Withdrawal symptoms caused by alcohol with seizures

7.1

24.6

R02

ICPC

Shortness of breath/dyspnoea

2.0

24.5

303

1641

JN3AA

NOMESCO Finland

Abdominal X-ray examination without contrast

2.8

24.5

124

455

XCK10

NOMESCO Finland

Photography of fundus of eye

2.1

24.5

242

1207

QDB05

NOMESCO Finland

Revision of wound of skin of lower limb

3.4

24.5

264

T36

ICD-10 Finland

Poisoning by systemic antibiotics

3.2

24.3

316

JL5CG

NOMESCO Finland

Extensive MRI examinaiton of bile and pancreas ducts with high intesity magnet

7.0

24.2

I10

ICD-10 Finland

Essential (primary) hypertension

1.7

24.2

1340

10976

A10BH02

ATC

vildagliptin; oral

3.9

24.1

186

NK6QA

NOMESCO Finland

Measurement of bone density from two or more locations with X-ray

2.6

23.9

151

620

K31.8

ICD-10 Finland

Other specified diseases of stomach and duodenum

9.2

23.9

H3600, E113,

ICD-10 Finland

5.1

23.8

100

J94.8

ICD-10 Finland

Other specified pleural conditions

4.4

23.5

141

JJA20

NOMESCO Finland

Open biopsy of liver

19.8

23.5

JN3KE

NOMESCO Finland

Abdominal ultrasound with added contrast

7.9

23.4

SPAT1255

SPAT

Intravenous administration of medicine

2.4

23.4

177

790

D13.1

ICD-10 Finland

Benign neoplasm: Stomach

4.0

23.4

172

323

Kela drug reimbursment

Sorafenib

36.7

23.0

R60.1

ICD-10 Finland

Generalized oedema

7.4

22.9

C01AA05

ATC

digoxin; systemic

2.2

22.9

207

996

K42.0

ICD-10 Finland

Umbilical hernia with obstruction, without gangrene

5.4

22.8

A10AB06

ATC

insulin glulisine; parenteral

5.6

22.8

B01AA03

ATC

warfarin; systemic

1.8

22.7

462

2924

KH1AE

NOMESCO Finland

Urinary tract ultrasound examination

2.4

22.7

166

730

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

1.9

22.6

317

1789

I48

ICD-10 Finland

Atrial fibrillation and flutter

1.7

22.6

532

3504

UJK02

NOMESCO Finland

ERCP

3.4

22.5

243

J18.9

ICD-10 Finland

Pneumonia, unspecified

1.7

22.4

567

3807

SPAT1254

SPAT

Administration of medicine

1.9

22.4

321

1825

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

1.6

22.3

646

4491

K55.2

ICD-10 Finland

Angiodysplasia of colon

7.7

22.1

201

Kela drug reimbursment

Chronic cardiac insufficiency

2.5

21.9

142

591

N05BA04

ATC

oxazepam; oral

1.7

21.8

511

3358

TK810

NOMESCO Finland

Hemofiltration

7.5

21.7

WZC00

NOMESCO Finland

Treatment plan or consultation

1.6

21.4

704

5037

A40.8

ICD-10 Finland

Other streptococcal sepsis

5.4

21.4

R56.8

ICD-10 Finland

Other and unspecified convulsions

2.7

21.4

121

471

F32.9

ICD-10 Finland

Depressive episode, unspecified

2.1

21.3

217

1093

I36.1

ICD-10 Finland

Nonrheumatic tricuspid (valve) insufficiency

4.6

21.3

114

E000001, ,

ATC

1.8

21.2

378

2299

Z3226

NOMESCO Finland

Physiotherapist

1.8

21.1

390

2397

A04.7

ICD-10 Finland

Enterocolitis due to Clostridium difficile

3.4

21.0

239

ZXE00

NOMESCO Finland

One hour or less

1.6

21.0

763

5584

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

2.4

20.9

149

647

E13.9

ICD-10 Finland

Other specified diabetes mellitus, without complications

5.4

20.9

TPH40

NOMESCO Finland

Insertion of a long peripheral venous catheter

8.1

20.9

K74

ICD-10 Finland

Fibrosis and cirrhosis of liver

+∞

20.9

PC2DE

NOMESCO Finland

Ultrasound examination of liver vasculature with Doppler method

+∞

20.9

202

Kela drug reimbursment

Connective tissue diseases, rheumatoid arthritis and comparable disease

2.0

20.9

237

1243

K76.89

ICD-10 Finland

Other specified diseases of liver

21.7

20.8

FM1BE

NOMESCO Finland

Cardiac ultrasound examination through oesophagus

2.2

20.5

178

841

K83.1

ICD-10 Finland

Obstruction of bile duct

4.5

20.4

110

N07BB01

ATC

disulfiram; oral

2.8

20.3

106

396

K55.8

ICD-10 Finland

Other vascular disorders of intestine

8.5

20.2

3039X

ICD-9 Finland

Alcohol dependence syndrome, Other and unspecified alcohol dependence

4.5

20.1

111

N39.0

ICD-10 Finland

Urinary tract infection, site not specified

1.9

20.0

308

1788

K77

ICPC

Heart failure

3.6

19.9

183

L01EX02

ATC

sorafenib; oral

58.1

19.9

WD505

NOMESCO Finland

Simple enzyme inhibitor or similar therapy of methastized malignancy

5.1

19.8

C09AA02

ATC

enalapril; systemic

1.7

19.8

448

2908

J01DB01

ATC

cefalexin; oral

1.7

19.8

1619

14199

A12BA01

ATC

potassium chloride; oral

2.6

19.8

113

442

A07EA06

ATC

budesonide; oral, local oral

3.0

19.7

296

R53

ICD-10 Finland

Malaise and fatigue

1.7

19.6

449

2921

A10AB04

ATC

insulin lispro; parenteral

3.2

19.5

245

D25

ICPC

Abdominal distension

4.0

19.5

144

UJF02

NOMESCO Finland

Peroral enteroscopy

7.2

19.5

D69.3

ICD-10 Finland

Idiopathic thrombocytopenic purpura

6.0

19.5

E88.0

ICD-10 Finland

Disorders of plasma-protein metabolism, not elsewhere classified

40.5

19.5

N08.39*E11.2

ICD-10 Finland

Non-insulin-dependent diabetes mellitus - Diabetic nephropathy

4.2

19.4

127

F10.00

ICD-10 Finland

Alcohol-related acute intoxication uncomplicated

4.2

19.4

123

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.6

19.3

790

5911

A10BJ01

ATC

exenatide; parenteral

4.8

19.2

JN1AD

NOMESCO Finland

CT examination of upper part of abdomen

7.3

19.1

K25.7

ICD-10 Finland

Gastric ulcer, Chronic without haemorrhage or perforation

5.1

19.1

ZXE50

NOMESCO Finland

More than nine and less than 12 hours

4.4

19.0

112

TPH20

NOMESCO Finland

Insertion of central venous catheter through subclavian or brachiocephalic vein

3.0

19.0

281

K25.0

ICD-10 Finland

Gastric ulcer, Acute with haemorrhage

4.8

19.0

K25.4

ICD-10 Finland

Gastric ulcer, Chronic or unspecified with haemorrhage

6.2

18.9

N10

ICD-10 Finland

Acute tubulo-interstitial nephritis

1.9

18.9

282

1620

TKC20

NOMESCO Finland

Catheterisation of bladder

2.2

18.8

172

830

K74.2

ICD-10 Finland

Hepatic fibrosis with hepatic sclerosis

+∞

18.8

3A422, ,

NOMESCO Finland

70.6

18.7

X69

ICD-10 Finland

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

3.4

18.5

207

Z02.7

ICD-10 Finland

Issue of medical certificate

2.2

18.4

153

710

358

Kela drug reimbursment

liraglutide

6.5

18.4

WZC20

NOMESCO Finland

Multidisciplinary treatment meeting

2.3

18.4

141

633

D73.1

ICD-10 Finland

Hypersplenism

30.3

18.3

SPAT1008

SPAT

Photography of fundus of the eye or interpretation of photograph

2.7

18.3

100

382

F10.40

ICD-10 Finland

Withdrawal symptoms and delirium caused by alcohol without seizures

5.0

18.3

B01AB05

ATC

enoxaparin; parenteral

1.6

18.3

656

4751

GA1AE

NOMESCO Finland

Ultrasound examination of thorax

3.3

18.0

216

K07

ICPC

Swollen ankles/oedema

2.5

17.9

118

494

F10.2

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Dependence syndrome

5.0

17.8

G63.2*E11.4

ICD-10 Finland

Non-insulin-dependent diabetes mellitus - Diabetic polyneuropathy

4.4

17.8

105

TFC00

NOMESCO Finland

Catheterisation of right atrium or ventricle

4.0

17.8

131

SPAT1222

SPAT

Counselling/guidance promoting independent living

1.8

17.8

326

1989

DKW00

NOMESCO Finland

Cauterisation of mucosa of nose

4.9

17.8

WX882

NOMESCO Finland

High dependency care

3.0

17.7

276

L02.4

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle of limb

3.0

17.6

277

F10.39

ICD-10 Finland

Withdrawal symptoms caused by alcohol UNS

4.9

17.6

JX1XE

NOMESCO Finland

Other ultrasound examinaton of alimentary organs

95.9

17.6

JJ7LT

NOMESCO Finland

Coagulation of focal hepatic lesion under CT guidance

95.9

17.6

I83.0

ICD-10 Finland

Varicose veins of lower extremities with ulcer

3.3

17.6

204

ZXE30

NOMESCO Finland

More than five and less than seven hours

2.4

17.5

118

500

L98.4

ICD-10 Finland

Chronic ulcer of skin, not elsewhere classified

3.3

17.0

198

K62.5

ICD-10 Finland

Haemorrhage of anus and rectum

2.4

16.9

123

539

F11.25

ICD-10 Finland

Relationship caused by opiates continuously used

25.8

16.9

E86

ICD-10 Finland

Volume depletion

3.1

16.9

235

F11.22

ICD-10 Finland

Addiction-induced dependence is currently independent but uses substitute intermittent medication

19.5

16.9

3AC01, ,

NOMESCO Finland

5.4

16.9

JL5SB

NOMESCO Finland

Endoscopic retrograd cholangiopancreaticography

3.9

16.8

132

C03EB01

ATC

furosemide and potassium-sparing agents; systemic

2.6

16.8

387

C02EA02, ,

ATC

2.5

16.8

111

466

R10.1

ICD-10 Finland

Pain localized to upper abdomen

1.7

16.8

334

2085

K86.1

ICD-10 Finland

Other chronic pancreatitis

5.1

16.7

JFA98

NOMESCO Finland

Other transluminal endoscopic local operation on intestine

3.4

16.6

186

E11.1

ICD-10 Finland

Type 2 diabetes mellitus, with ketoacidosis

6.7

16.6

D07AC01

ATC

betamethasone; topical

1.5

16.5

695

5188

SPAT1083

SPAT

Initiation and monitoring of IV fluid therapy

2.4

16.3

112

478

A10AE06

ATC

insulin degludec; parenteral

2.8

16.3

289

IAZ97

NOMESCO Finland

Psychiatric consultation in another specialty

4.3

16.2

100

WX402

NOMESCO Finland

General anaesthesia

1.6

16.2

407

2697

B18.1

ICD-10 Finland

Chronic viral hepatitis B without delta-agent

15.5

16.2

J44.8

ICD-10 Finland

Other specified chronic obstructive pulmonary disease

1.9

16.2

238

1358

E0000UV, ,

ATC

1.5

16.1

750

5711

N06AX11

ATC

mirtazapine; oral

1.5

15.7

629

4638

GA4AT

NOMESCO Finland

Cathetrisation of pleural cavity with ultrasound guidance

4.1

15.6

103

TJA40

NOMESCO Finland

Percutaneous local drainage of peritoneal cavity

26.5

15.6

K86.00

ICD-10 Finland

Acute pancreatitis caused by alcohol

4.2

15.6

J45.9

ICD-10 Finland

Asthma, unspecified

1.7

15.6

357

2310

S76

ICPC

Skin infection other

2.3

15.6

125

572

D12.2

ICD-10 Finland

Benign neoplasm: Ascending colon

2.6

15.5

349

SPAT1217

SPAT

Assessment of need for services (elderly/care support)

2.0

15.5

168

864

JN1BD

NOMESCO Finland

Extensive CT examination of upper part of abdomen

5.4

15.4

ZXE20

NOMESCO Finland

More than three and less than five hours

1.7

15.4

300

1859

L03.1

ICD-10 Finland

Cellulitis of other parts of limb

2.9

15.4

243

K25.3

ICD-10 Finland

Gastric ulcer, Acute without haemorrhage or perforation

4.9

15.2

JJ3AT

NOMESCO Finland

Cytology of liver with ultrasound guidance

28.8

15.2

H3601, E113,

ICD-10 Finland

3.5

15.2

147

TQX10

NOMESCO Finland

Biopsy of skin and subcutaneous tissue

1.9

15.0

210

1179

K26.9

ICD-10 Finland

Duodenal ulcer, unspecified as acute or chronic, without haemorrhage or perforation

4.7

15.0

K65.9

ICD-10 Finland

Peritonitis, unspecified

15.2

14.9

K31.7

ICD-10 Finland

Polyp of stomach and duodenum

6.8

14.9

K80.3

ICD-10 Finland

Calculus of bile duct with cholangitis

5.1

14.8

PC2SC

NOMESCO Finland

Liver angiography with X-ray

57.1

14.8

I87.2

ICD-10 Finland

Venous insufficiency (chronic)(peripheral)

1.8

14.7

219

1252

F32.10

ICD-10 Finland

Moderate depressive episode without somatic syndrome

2.2

14.7

131

625

D50

ICD-10 Finland

Iron deficiency anaemia

3.5

14.7

150

I11.0

ICD-10 Finland

Hypertensive heart disease with (congestive) heart failure

2.8

14.7

266

R70.0

ICD-10 Finland

Elevated erythrocyte sedimentation rate

3.1

14.7

201

WX419

NOMESCO Finland

Other general anesthesy

5.0

14.5

123

Kela drug reimbursment

Chronic disorders of vitamin D metabolism

3.0

14.5

218

R4190

NOMESCO Finland

Nutritional therapy

2.6

14.5

337

319

Kela drug reimbursment

Adalimumab, brodalumab, certolizumab pegol, etanercept, guselkumab, infliximab, ixekizumab, risankizumab, sekukinumab and ustekinumab (skin psoriasis)

6.6

14.5

J01EE01

ATC

sulfamethoxazole and trimethoprim; systemic

2.2

14.5

129

616

Z72.1

ICD-10 Finland

Alcohol use

4.1

14.5

XPX99

NOMESCO Finland

Other diagnostic examination of periferal vessel

2.0

14.4

159

823

Z01.8

ICD-10 Finland

Other specified special examinations

1.6

14.4

442

3066

WZC30

NOMESCO Finland

Teaching

1.7

14.4

333

2158

ZXD10

NOMESCO Finland

Scheduled procedure

1.5

14.3

735

5672

Z71.3

ICD-10 Finland

Dietary counselling and surveillance

2.4

14.2

401

B03XA03

ATC

methoxy polyethylene glycol-epoetin beta; parenteral

6.2

14.2

XF600

NOMESCO Finland

Bloodpressure measurement

2.1

14.1

142

710

F10.09

ICD-10 Finland

Alcohol intoxication UNS

3.3

14.1

164

SPAT1265

SPAT

Breathalyser

4.8

14.0

F05.9

ICD-10 Finland

Delirium, unspecified

3.1

14.0

196

K80.5

ICD-10 Finland

Calculus of bile duct without cholangitis or cholecystitis

2.8

14.0

256

K08.1

ICD-10 Finland

Loss of teeth due to accident, extraction or local periodontal disease

1.7

13.9

255

1552

K85.9

ICD-10 Finland

Acute pancreatitis, unspecified

3.3

13.9

166

SPAT1306

SPAT

Counselling and guidance related to nutrition and weight management

1.7

13.8

260

1592

D69.5

ICD-10 Finland

Secondary thrombocytopenia

11.5

13.8

JAH00

NOMESCO Finland

Laparotomy

2.7

13.8

281

L04AA01

ATC

[U] ciclosporin

4.1

13.8

A10AD01

ATC

insulin (human); parenteral

3.7

13.6

119

K76.1

ICD-10 Finland

Chronic passive congestion of liver

75.7

13.6

ZXE02

NOMESCO Finland

Procedure duration 10 to 19 minutes

2.3

13.5

103

461

3A064, ,

NOMESCO Finland

11.0

13.5

T74.1

ICD-10 Finland

Physical abuse

4.1

13.5

JJA44

NOMESCO Finland

Laparoscopic destruction of lesion of liver

140.9

13.5

A10BG02

ATC

rosiglitazone; oral

3.4

13.4

144

RS221, ,

NOMESCO Finland

3.8

13.4

106

T89

ICPC

Diabetes insulin dependent

2.5

13.4

332

F10.26

ICD-10 Finland

Alcohol dependence periodic alcoholism

3.6

13.4

125

601

Kela drug reimbursment

Severe malabsorption of nutrients, mainly fats

4.3

13.4

ZXM00

NOMESCO Finland

Intraoperative use of ultrasonographic imaging

4.5

13.3

K08.3

ICD-10 Finland

Retained dental root

1.9

13.3

166

897

N05AH04

ATC

quetiapine; oral

1.7

13.2

298

1914

E03.9

ICD-10 Finland

Hypothyroidism, unspecified

1.8

13.2

227

1355

D07XC01

ATC

betamethasone; topical

1.7

13.2

247

1511

TJD00

NOMESCO Finland

Insertion of nasogastric or naso-gastroduodenal tube

4.1

13.1

D05AX02

ATC

calcipotriol; topical

2.4

13.0

374

R58

ICD-10 Finland

Haemorrhage, not elsewhere classified

3.6

13.0

118

M01AB01

ATC

indometacin; systemic, rectal

1.9

13.0

182

1021

C09AA05

ATC

ramipril; oral

1.5

13.0

551

4080

A02BC01

ATC

omeprazole; systemic

1.5

13.0

522

3824

C03EA01

ATC

hydrochlorothiazide and potassium-sparing agents; oral

1.6

13.0

304

1972

SPAT1230

SPAT

Aid fitting and borrowing and monitoring of use

1.6

12.8

323

2132

K26.0

ICD-10 Finland

Duodenal ulcer, acute with haemorrhage

4.6

12.8

WX000

NOMESCO Finland

Monitoring vital functions without anesthesy

2.4

12.8

395

D02AE01

ATC

carbamide; topical

2.1

12.8

130

653

GD1DD

NOMESCO Finland

High resolution CT examination of lungs

2.1

12.7

116

559

K52.9

ICD-10 Finland

Noninfective gastroenteritis and colitis, unspecified

2.5

12.7

341

SPAT1229

SPAT

Assessment of need for aid

1.9

12.7

168

926

WZB00

NOMESCO Finland

Telephone prescription or other care instructions

1.5

12.6

494

3595

F19.25

ICD-10 Finland

Addiction caused by several drugs in combination and by other psychoactive substances continuously used

15.5

12.6

Z72.2

ICD-10 Finland

Drug use

15.5

12.6

E87.2

ICD-10 Finland

Acidosis

5.5

12.6

SPAT1309

SPAT

Guidance related to psychoactive substances / risk behaviour

2.9

12.6

203

A10BX02

ATC

repaglinide; oral

3.6

12.6

116

A10BB07

ATC

glipizide; oral

3.8

12.6

102

N05BA01

ATC

diazepam; systemic, rectal

1.7

12.6

250

1554

E78.0

ICD-10 Finland

Pure hypercholesterolaemia

0.6

12.5

184

3061

JDA32

NOMESCO Finland

Endoscopic injection in stomach or pylorus

11.1

12.5

A03FA01

ATC

metoclopramide; systemic, rectal

1.5

12.4

402

2810

9694A

ICD-9 Finland

Poisoning by psychotropic agents, Benzodiazepine-based tranquillisers

5.7

12.4

N03AX16

ATC

[U] pregabalin

1.5

12.4

449

3214

ZXE03

NOMESCO Finland

Procedure duration 20 to 29 minutes

2.1

12.3

118

580

B99

ICD-10 Finland

Other and unspecified infectious diseases

3.1

12.3

168

SPAT1156

SPAT

Guidance concerning treatment of rash and skin

1.7

12.3

272

1738

OAB43, ,

SPAT

0.5

12.2

102

2024

DM1QA

NOMESCO Finland

Paranasal sinuses X-ray examination in one projection

2.3

12.2

398

N47

ICD-10 Finland

Redundant prepuce, phimosis and paraphimosis

2.5

12.1

330

C07AB02

ATC

metoprolol; systemic

1.5

12.1

412

2909

R11

ICD-10 Finland

Nausea and vomiting

1.9

12.1

156

852

F10.30

ICD-10 Finland

Withdrawal symptoms caused by alcohol uncomplicated

4.2

12.1

SPAT1225

SPAT

Implementation of podiatry rehabilitation plan

2.7

12.0

242

B03XA02

ATC

darbepoetin alfa; parenteral

2.8

12.0

225

3018X

ICD-9 Finland

Personality disorders, Other personality disorders[MUU TAI SEKAMUOTOINEN PERSOONALLISUUSHÄIRIÖ]

5.3

12.0

A07AA09

ATC

vancomycin; oral

3.6

12.0

110

F11.24

ICD-10 Finland

Addiction-induced dependence caused by opiates active addiction

21.4

12.0

JDA05

NOMESCO Finland

Endoscopic polypectomy in stomach or pylorus

10.1

12.0

FM1DE

NOMESCO Finland

Doppler ultrasound examination of heart

1.8

11.9

204

1215

WX213

NOMESCO Finland

Lower leg blockade

4.9

11.9

L08.8

ICD-10 Finland

Other specified local infections of skin and subcutaneous tissue

2.6

11.9

279

WW200, ,

SPAT

0.6

11.8

199

3196

C03AA03

ATC

hydrochlorothiazide; oral

1.8

11.7

199

1183

R03BB04

ATC

tiotropium bromide; inhalant

1.7

11.7

222

1362

ZZA00

NOMESCO Finland

Split skin graft

2.5

11.6

282

474, ,

NOMESCO Finland

65.3

11.6

R77.0

ICD-10 Finland

Abnormality of albumin

65.3

11.6

I48.2

ICD-10 Finland

Chronic atrial fibrillation

2.2

11.6

100

472

WPA10

NOMESCO Finland

Proactive palliative care treatment plan

5.3

11.5

RD210, ,

NOMESCO Finland

3.2

11.5

138

J01DA01

ATC

[U] cefalexin

1.4

11.5

1133

9681

D07AD01

ATC

clobetasol; topical

1.6

11.5

301

2003

K76.4

ICD-10 Finland

Peliosis hepatis

+∞

11.5

F15.2

ICD-10 Finland

Mental and behavioural disorders due to use of other stimulants, including caffeine, dependence syndrome

13.7

11.5

SPAT1263

SPAT

Sampling

1.4

11.4

745

5941

130

Kela drug reimbursment

Malignant tumour

1.7

11.4

200

1199

N06AB04

ATC

citalopram; systemic

1.5

11.4

370

2583

G31.2

ICD-10 Finland

Degeneration of nervous system due to alcohol

4.7

11.4

JAF30

NOMESCO Finland

Repair of umbilical hernia using prosthetic material

2.7

11.4

220

I42.9

ICD-10 Finland

Cardiomyopathy, unspecified

3.4

11.4

119

A10BD03

ATC

metformin and rosiglitazone; systemic

3.0

11.4

160

FB1BD

NOMESCO Finland

Extensive CT examination of arteria pulmonalis

1.8

11.3

163

922

F19.1

ICD-10 Finland

Mental and behavioural disorders due to multiple drug use and use of other psychoactive substances, harmful use

11.9

11.3

JKD20

NOMESCO Finland

Anastomosis of bile duct to jejunum

35.2

11.3

K75.8

ICD-10 Finland

Other specified inflammatory liver diseases

35.2

11.3

F10.21

ICD-10 Finland

Alcohol dependence currently abstinent, but staying in restrictive environment

4.4

11.2

K02.2

ICD-10 Finland

Caries of cementum

2.1

11.2

109

539

K81.0

ICD-10 Finland

Acute cholecystitis

2.9

11.2

183

A41.1

ICD-10 Finland

Sepsis due to other specified staphylococcus

4.6

11.2

A04

ICPC

Weakness/tiredness general

1.6

11.2

258

1665

R16.1

ICD-10 Finland

Splenomegaly, not elsewhere classified

25.2

11.1

S42.2

ICD-10 Finland

Fracture of upper end of humerus

2.2

11.1

447

K81.9

ICD-10 Finland

Cholecystitis, unspecified

4.2

11.1

F19.29

ICD-10 Finland

Addiction caused by several drugs in combination and by other psychoactive substances UNS

11.2

11.0

RS120, ,

NOMESCO Finland

11.2

11.0

H36.00

ICD-10 Finland

Diabetic background retinopathy

3.6

11.0

102

B01AB04

ATC

dalteparin; parenteral

2.1

11.0

105

516

S18

ICPC

Laceration/cut

1.4

11.0

899

7432

H36.01

ICD-10 Finland

Diabetic maculopathy

3.4

11.0

117

L02.2

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle of trunk

2.2

11.0

397

L01EX08

ATC

lenvatinib; oral

43.6

10.9

K70

ICD-10 Finland

Alcoholic liver disease

43.6

10.9

Z3229

NOMESCO Finland

Other healthcare associate professional

1.8

10.9

168

970

GD1AD

NOMESCO Finland

Thorax CT examination

1.9

10.9

132

706

R03AC02

ATC

salbutamol; inhalant

1.4

10.9

958

8009

A98

ICPC

Health maint/preventive medicine

0.6

10.9

1690

17936

K65.8

ICD-10 Finland

Other peritonitis

12.0

10.8

L17

ICPC

Foot/toe symptom/complaint

1.4

10.8

520

3922

F15.1

ICD-10 Finland

Mental and behavioural disorders due to use of other stimulants, including caffeine, harmful use

15.6

10.8

SPAT1216

SPAT

Assessment of functional ability

1.6

10.8

309

2097

JDA42

NOMESCO Finland

Other endoscopic haemostatic procedure in stomach or pylorus

8.3

10.8

K22.6

ICD-10 Finland

Gastro-oesophageal laceration-haemorrhage syndrome

5.2

10.8

3019

Kela drug reimbursment

Lenvatinib

28.2

10.7

JKA20

NOMESCO Finland

Cholecystectomy

2.5

10.7

263

JDA22

NOMESCO Finland

Endoscopic ligature of varices of stomach

21.6

10.7

N30.0

ICD-10 Finland

Acute cystitis

1.6

10.7

246

1586

K51.5

ICD-10 Finland

Left sided colitis

2.6

10.7

228

F10.9

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Unspecified mental and behavioural disorder

4.3

10.6

ZY010

NOMESCO Finland

Hospital outpatient

2.2

10.5

384

K29.2

ICD-10 Finland

Alcoholic gastritis

11.3

10.5

UJK12

NOMESCO Finland

Peroral cholangioscopy

14.3

10.5

B01AB10

ATC

tinzaparin; parenteral

1.7

10.5

200

1228

WX730

NOMESCO Finland

Conventional respirator

3.2

10.4

126

H02AB07

ATC

prednisone; oral

1.6

10.4

259

1701

R73.9

ICD-10 Finland

Hyperglycaemia, unspecified

2.4

10.4

279

B03BA03

ATC

hydroxocobalamin; parenteral

2.0

10.4

117

611

B17.1

ICD-10 Finland

Acute hepatitis C

32.7

10.3

1508

Kela drug reimbursment

Lenvatinib

32.7

10.3

ZXE10

NOMESCO Finland

More than one and less than three hours

1.4

10.3

679

5402

E66.2

ICD-10 Finland

Extreme obesity with alveolar hypoventilation

4.0

10.3

N05BA12

ATC

alprazolam; oral

1.7

10.2

181

1088

S81.8

ICD-10 Finland

Open wound of other parts of lower leg

2.3

10.2

331

ZXE05

NOMESCO Finland

Procedure duration 40 to 49 minutes

2.1

10.2

469

T81.0

ICD-10 Finland

Haemorrhage and haematoma complicating a procedure, not elsewhere classified

1.9

10.2

123

657

A07EC02

ATC

mesalazine; oral, rectal

2.1

10.2

102

510

SPAT1253

SPAT

Initiation, adjustment, discontinuation or repetition of medication

1.4

10.2

537

4112

Z94.0

ICD-10 Finland

Kidney transplant status

3.7

10.2

ZXD30

NOMESCO Finland

Difficulties in perfomrming procedure

2.1

10.1

430

M10.0

ICD-10 Finland

Idiopathic gout

2.2

10.1

411

2500A

ICD-9 Finland

Diabetes mellitus without mention of complication[DIABETES MELLITUS SINE COMPLICATIONE,TYYPPI II]

2.8

10.1

183

TGC00

NOMESCO Finland

Bronchial lavation

2.5

10.1

241

A11CC03

ATC

alfacalcidol; systemic

2.6

10.0

224

ZXE04

NOMESCO Finland

Procedure duration 30 to 39 minutes

2.0

10.0

115

605

K51.9

ICD-10 Finland

Ulcerative colitis, unspecified

2.5

10.0

266

F60.9

ICD-10 Finland

Personality disorder, unspecified

4.1

10.0

Z03.5

ICD-10 Finland

Observation for other suspected cardiovascular diseases

1.8

10.0

151

868

I50.1

ICD-10 Finland

Left ventricular failure

2.0

9.9

113

592

JAF10

NOMESCO Finland

Repair of umbilical hernia

2.4

9.9

267

K83.8

ICD-10 Finland

Other specified diseases of biliary tract

12.2

9.8

P19

ICPC

Drug abuse

8.1

9.8

I70.2

ICD-10 Finland

Atherosclerosis of arteries of extremities

1.7

9.8

198

1235

I48.1

ICD-10 Finland

Persistent atrial fibrillation

2.1

9.7

431

NA3AA

NOMESCO Finland

Lumbar spine X-ray examination without contrast

1.7

9.7

187

1151

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

1.5

9.7

329

2314

F19.20

ICD-10 Finland

Addiction relationship caused by several drugs in combination and by other psychoactive substances currently independent

13.4

9.7

D70.89

ICD-10 Finland

Neutropenic splenomegaly

3.6

9.7

I25.1

ICD-10 Finland

Atherosclerotic heart disease

1.4

9.6

489

3714

EBA00

NOMESCO Finland

Extraction of tooth

1.4

9.6

637

5060

C22.1

ICD-10 Finland

Malignant neoplasm: Intrahepatic bile duct carcinoma

7.8

9.6

XLD00

NOMESCO Finland

Sytologyspecimen from mouth of uterus

1.9

9.6

128

707

2780A

ICD-9 Finland

Obesity and other hyperalimentation, Obesity

4.8

9.5

A10BX01

ATC

guar gum; oral

2.2

9.5

381

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

1.6

9.5

204

1291

F11.29

ICD-10 Finland

Addiction caused by opiates UNS

15.1

9.5

L89

ICD-10 Finland

Decubitus ulcer and pressure area

2.9

9.5

155

N05AA02

ATC

levomepromazine; systemic

2.2

9.5

368

WX404

NOMESCO Finland

Intravenous generell anesthesy

1.5

9.5

355

2546

R2130

NOMESCO Finland

Counselling and guidance which enhance independent living

1.7

9.5

161

957

K63.5

ICD-10 Finland

Polyp of colon

2.7

9.5

195

I33.0

ICD-10 Finland

Acute and subacute infective endocarditis

4.1

9.4

GAA10

NOMESCO Finland

Intercostal insertion of pleural drainage tube

2.9

9.4

156

Z94.9

ICD-10 Finland

Transplanted organ and tissue status, unspecified

17.6

9.4

C22

ICD-10 Finland

Malignant neoplasm of liver and intrahepatic bile ducts

+∞

9.4

I98.2

ICD-10 Finland

Oesophageal varices without bleeding in diseases classified elsewhere

+∞

9.4

208

Kela drug reimbursment

Ulcerative colitis and Crohn's disease

2.1

9.4

410

E11.5

ICD-10 Finland

Type 2 diabetes mellitus, with peripheral circulatory complications

2.6

9.4

196

RJ411, ,

NOMESCO Finland

5.2

9.4

WVA40

NOMESCO Finland

Initiation and monitoring of intravenous hydration

3.1

9.4

119

F32.2

ICD-10 Finland

Severe depressive episode without psychotic symptoms

2.0

9.3

100

513

S91.3

ICD-10 Finland

Open wound of other parts of foot

2.6

9.3

208

Z71.8

ICD-10 Finland

Other specified counselling

1.4

9.3

499

3822

D05BB02

ATC

acitretin; oral

2.5

9.3

226

D07AA02

ATC

hydrocortisone; topical

1.6

9.3

220

1426

K50.8

ICD-10 Finland

Other Crohn disease

3.3

9.3

104

ZY020

NOMESCO Finland

Telephone, letter or other consultation without direct patient contact

1.9

9.3

123

678

F13.20

ICD-10 Finland

Addiction relationship caused by sedatives and hypnotics currently independent

10.7

9.3

S29

ICPC

Skin symptom/complaint other

1.5

9.2

341

2438

I48.9

ICD-10 Finland

Atrial fibrillation and atrial flutter, unspecified

1.8

9.2

153

903

L40.9

ICD-10 Finland

Psoriasis, unspecified

3.1

9.2

120

K80.8

ICD-10 Finland

Other cholelithiasis

2.9

9.2

147

T31

ICPC

Metabolic, Medical examin/health eval partial

4.2

9.2

C09BA02

ATC

enalapril and diuretics; systemic

1.7

9.2

172

1051

QX2XE

NOMESCO Finland

Ultrsound examination of soft tissue not elsewhere classified

2.4

9.1

271

Z49.1

ICD-10 Finland

Extracorporeal dialysis

3.1

9.1

126

K43.9

ICD-10 Finland

Other and unspecified ventral hernia without obstruction or gangrene

2.0

9.1

476

Z76.9

ICD-10 Finland

Person encountering health services in unspecified circumstances

1.7

9.1

159

953

XX1AT

NOMESCO Finland

Other puncture with ultrasound guidance

3.5

9.1

CJE20

NOMESCO Finland

Phakoemulsification with implantation of artificial lens in posterior chamber

1.4

9.0

625

4989

JCA42

NOMESCO Finland

Other endoscopic procedure for hemostasis

15.6

9.0

K86.2

ICD-10 Finland

Cyst of pancreas

3.7

9.0

XJD02

NOMESCO Finland

Peroral endoscopic ultrasonography

3.7

9.0

R06AE07

ATC

cetirizine; oral

1.4

9.0

700

5691

I42.0

ICD-10 Finland

Dilated cardiomyopathy

2.4

9.0

267

K57.3

ICD-10 Finland

Diverticular disease of large intestine without perforation or abscess

1.5

9.0

369

2693

I11.9

ICD-10 Finland

Hypertensive heart disease without (congestive) heart failure

2.0

9.0

493

WXQ27

NOMESCO Finland

UVB narrow spectrum light therapy

3.5

8.9

L29.9

ICD-10 Finland

Pruritus, unspecified

2.5

8.9

213

R03AL01

ATC

fenoterol and ipratropium bromide; inhalant

2.2

8.9

345

K50.9

ICD-10 Finland

Crohn disease, unspecified

3.3

8.9

D13.2

ICD-10 Finland

Benign neoplasm: Duodenum

4.4

8.9

K80.0

ICD-10 Finland

Calculus of gallbladder with acute cholecystitis

2.1

8.9

433

E83.51

ICD-10 Finland

Hypocalcemia

4.7

8.8

C10AA07

ATC

rosuvastatin; oral

0.7

8.8

378

5005

D07AB08

ATC

desonide; topical

1.6

8.7

183

1151

I78.8

ICD-10 Finland

Other diseases of capillaries

14.1

8.7

2BD01, ,

NOMESCO Finland

14.1

8.7

K73.0

ICD-10 Finland

Chronic persistent hepatitis, not elsewhere classified

50.2

8.7

J01CF05

ATC

flucloxacillin; systemic

1.9

8.7

116

642

K80

ICD-10 Finland

Cholelithiasis

3.5

8.7

R91

ICD-10 Finland

Abnormal findings on diagnostic imaging of lung

1.6

8.6

208

1354

S10

ICPC

Boil/carbuncle

1.9

8.6

109

592

E16.2

ICD-10 Finland

Hypoglycaemia, unspecified

3.3

8.6

F33.2

ICD-10 Finland

Recurrent depressive disorder, current episode severe without psychotic symptoms

2.2

8.6

317

SPAT1137

SPAT

Taking care of patient’s/customer’s hygiene

1.9

8.6

113

622

R03AK03

ATC

[U] fenoterol and ipratropium bromide

1.9

8.6

103

550

D02AX

ATC

Other emollients and protectives

2.4

8.6

229

320

Kela drug reimbursment

Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide

4.6

8.6

OAA67, ,

SPAT

0.4

8.6

1054

C08CA01

ATC

amlodipine; oral

1.3

8.6

779

6469

JKE18

NOMESCO Finland

Endoscopic internal drainage of bile duct

3.5

8.5

TPH05

NOMESCO Finland

Open cannulation of peripheral vein

3.8

8.5

TFB00

NOMESCO Finland

Cathetrisation of pulmonal artery

2.6

8.5

188

D47.2

ICD-10 Finland

Monoclonal gammopathy of undetermined significance (MGUS)

3.2

8.5

100

N17.0

ICD-10 Finland

Acute renal failure with tubular necrosis

6.4

8.5

I89.0

ICD-10 Finland

Lymphoedema, not elsewhere classified

4.2

8.5

K85

ICD-10 Finland

Acute pancreatitis

2.8

8.4

143

R04.2

ICD-10 Finland

Haemoptysis

2.1

8.4

373

ZXE11

NOMESCO Finland

Procedure duration 60 to 89 minutes

2.0

8.4

476

K74.4

ICD-10 Finland

Secondary biliary cirrhosis

90.4

8.4

5716A

ICD-9 Finland

Chronic liver disease and cirrhosis, Biliary cirrhosis[CIRRHOSIS BILIARIS PRIMARIA]

90.4

8.4

Y83

ICD-10 Finland

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1.8

8.4

134

783

D07BA04

ATC

hydrocortisone and antiseptics; topical

1.7

8.4

156

952

D12.4

ICD-10 Finland

Benign neoplasm: Descending colon

2.6

8.4

178

N18.0

ICD-10 Finland

End-stage renal disease

3.4

8.4

TPH90

NOMESCO Finland

Removal of fixed intravenous catheter

3.3

8.4

E950A

ICD-9 Finland

Suicide and self-inflicted poisoning by solid or liquid substances

3.8

8.3

K02.9

ICD-10 Finland

Dental caries, unspecified

2.9

8.3

133

JJC60

NOMESCO Finland

Total excision of transplanted liver

+∞

8.3

E000006, ,

ATC

1.8

8.3

116

652

Z03.89

ICD-10 Finland

Observation for other suspected diseases and conditions

1.5

8.2

241

1640

FN1AC

NOMESCO Finland

Angiography of heart and/or coronary arteries

1.4

8.2

492

3828

4019X

ICD-9 Finland

Essential hypertension, Unspecified

2.3

8.2

278

PBL10

NOMESCO Finland

Construction of arteriovenous fistula from radial artery

3.3

8.2

N05AB01

ATC

dixyrazine; systemic

3.3

8.2

B81

ICPC

Anaemia vit B12/folate deficiency

2.1

8.2

377

I83.2

ICD-10 Finland

Varicose veins of lower extremities with both ulcer and inflammation

4.2

8.2

N06AB10

ATC

escitalopram; oral

1.5

8.2

291

2063

J02AC01

ATC

fluconazole; systemic

1.4

8.1

560

4454

M10

ICD-10 Finland

Gout

1.9

8.1

101

546

Z71.4

ICD-10 Finland

Alcohol abuse counselling and surveillance

4.6

8.1

SPAT1269

SPAT

Other puncture and/or drainage

4.8

8.1

D77

ICPC

Malignant digestive neopl other/NOS

4.8

8.1

P16

ICPC

Acute alcohol abuse

3.0

8.1

119

M01AH05

ATC

etoricoxib; oral

0.8

8.1

837

9734

D63.8

ICD-10 Finland

Anaemia in other chronic diseases classified elsewhere

8.2

8.1

J44.9

ICD-10 Finland

Chronic obstructive pulmonary disease, unspecified

1.9

8.1

526

F60.30

ICD-10 Finland

Emotionally unstable personality disorder, impulsive

3.8

8.1

PD1AD

NOMESCO Finland

CT of abdominal aorta and branches

4.0

8.1

N02AB03

ATC

fentanyl; nasal, sublingual, transdermal

1.9

8.1

512

F33.10

ICD-10 Finland

Recurrent depression, moderate episode without somatic syndrome

2.1

8.0

353

SPAT1301

SPAT

No procedures

1.4

8.0

558

4443

L84

ICD-10 Finland

Corns and callosities

2.1

8.0

340

F19.30

ICD-10 Finland

Withdrawal symptoms caused by several drugs in combination and by other psychoactive substances uncomplicated

22.1

8.0

FPE00

NOMESCO Finland

Implantation of transvenous cardiac pacemaker with ventricular electrode

2.5

8.0

206

EBA10

NOMESCO Finland

Operative extraction of tooth

1.6

8.0

168

1058

Z71.2

ICD-10 Finland

Person consulting for explanation of investigation findings

1.4

8.0

461

3565

Z71.9

ICD-10 Finland

Counselling, unspecified

1.8

8.0

117

667

N06AX03

ATC

mianserin; oral

1.9

7.9

486

L40

ICD-10 Finland

Psoriasis

2.7

7.9

148

KGH10

NOMESCO Finland

Operation for phimosis

2.3

7.9

263

M86.9

ICD-10 Finland

Osteomyelitis, unspecified

3.7

7.9

L03.9

ICD-10 Finland

Cellulitis, unspecified

2.7

7.9

160

N06AX16

ATC

venlafaxine; oral

1.6

7.9

213

1424

EB1WA, ,

NOMESCO Finland

4.6

7.9

30041

ICD-8 Finland

Neuroses, Depressiva

3.0

7.8

111

377

Kela drug reimbursment

Apremilast and dimethyl fumarate (psoriasis)

9.4

7.8

SPAT1251

SPAT

Organisation of medication

2.2

7.8

311

R31

ICD-10 Finland

Unspecified haematuria

1.5

7.8

218

1470

L30.9

ICD-10 Finland

Dermatitis, unspecified

1.4

7.8

330

2419

A02BC05

ATC

esomeprazole; systemic

1.3

7.7

729

6061

B02AA02

ATC

tranexamic acid; systemic

1.6

7.7

197

1300

JA3GT

NOMESCO Finland

Insertion of tunnelled ascites drain

45.2

7.7

602

Kela drug reimbursment

Children's severe malnutrition

15.1

7.7

190

Kela drug reimbursment

Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide

3.6

7.7

H26.3

ICD-10 Finland

Drug-induced cataract

4.3

7.7

A08.4

ICD-10 Finland

Viral intestinal infection, unspecified

2.4

7.7

223

H03AA01

ATC

levothyroxine sodium; systemic

1.4

7.6

366

2741

OAA80, ,

SPAT

0.3

7.6

641

WW200

NOMESCO Finland

Immunization

2.4

7.6

224

ZXD35

NOMESCO Finland

Usual procedure

2.2

7.6

288

D12.3

ICD-10 Finland

Benign neoplasm: Transverse colon

2.2

7.6

275

N40

ICD-10 Finland

Hyperplasia of prostate

0.7

7.6

309

4144

K29.8

ICD-10 Finland

Duodenitis

3.5

7.5

321

Kela drug reimbursment

Paricalcitol and cinacalcet

4.1

7.5

K83.9

ICD-10 Finland

Disease of biliary tract, unspecified

6.2

7.5

212

Kela drug reimbursment

Gout

2.4

7.5

206

A08AB01

ATC

orlistat; oral

3.8

7.5

F31.9

ICD-10 Finland

Bipolar affective disorder, unspecified

2.7

7.5

141

C07AB03

ATC

atenolol; systemic

1.8

7.5

117

680

XF622

NOMESCO Finland

Measurement of minute volume of heart

7.1

7.5

SPAT1139

SPAT

Nutrition survey

2.1

7.4

310

F10.49

ICD-10 Finland

Withdrawal symptoms and delirium caused by alcohol without information about seizures

4.4

7.4

I25.0

ICD-10 Finland

Atherosclerotic cardiovascular disease, so described

1.7

7.4

128

765

3044A

ICD-9 Finland

Drug dependence, Amphetamine and other psychostimulant dependence

80.4

7.4

A03

ICPC

Fever

1.5

7.4

237

1644

QDG20

NOMESCO Finland

Operation for chronic ulcer or fistula of skin of lower limb

3.3

7.4

I27.2

ICD-10 Finland

Other secondary pulmonary hypertension

6.0

7.4

R06

ICPC

Nose bleed/epistaxis

2.4

7.4

196

L40.8

ICD-10 Finland

Other psoriasis

3.8

7.4

N06AA12

ATC

doxepin; systemic

1.8

7.3

543

N06AB03

ATC

fluoxetine; oral

1.5

7.3

202

1357

R40.2

ICD-10 Finland

Coma, unspecified

3.6

7.3

ND2AA

NOMESCO Finland

Hand and fingers X-ray examination

1.6

7.3

155

979

RS321, ,

NOMESCO Finland

+∞

7.3

RS122, ,

NOMESCO Finland

9.4

7.3

N05BE01

ATC

buspirone; oral

2.3

7.3

241

D01

ICPC

Abdominal pain/cramps general

1.6

7.3

179

1172

3050A

ICD-9 Finland

Nondependent abuse of drugs, Alcohol abuse

3.4

7.3

UJF45

NOMESCO Finland

Flexible sigmoidoscopy with biopsy

1.6

7.2

157

997

H25.8

ICD-10 Finland

Other senile cataract

1.5

7.2

215

1468

SPAT1281

SPAT

Other administrative function

1.7

7.2

139

856

M01AE03

ATC

ketoprofen; systemic, rectal

1.3

7.2

672

5567

TPX10

NOMESCO Finland

Implantation of vascular injection port

2.2

7.2

281

TJA00

NOMESCO Finland

Puncture of peritoneum

30.1

7.1

D23

ICPC

Hepatomegaly

30.1

7.1

L04AA10

ATC

[U] sirolimus

30.1

7.1

J01AA02

ATC

doxycycline; systemic

1.3

7.1

1455

13346

JKE25

NOMESCO Finland

Endoscopic external drainage of bile duct

6.6

7.1

H3602, E113,

ICD-10 Finland

7.9

7.1

I95.2

ICD-10 Finland

Hypotension due to drugs

3.8

7.1

E000003, ,

ATC

2.0

7.1

371

R10.0

ICD-10 Finland

Acute abdomen

2.2

7.1

257

SPAT1149

SPAT

Suture or treatment of traumatic wound

1.5

7.1

236

1651

Y57

ICD-10 Finland

Adverse effects in the therapeutic use of other and unspecified drugs and medicaments

2.5

7.0

164

K05.31

ICD-10 Finland

Periodontitis pronounced

1.5

7.0

214

1470

T45

ICPC

Metabolic, Observ/health educat/advice/diet

2.8

7.0

124

310

Kela drug reimbursment

Orlistat, sibutramine and other major and expensive medicines used to treat obesity

3.0

7.0

102

OAB74

NOMESCO Finland

Nutritional guidance related to treatment and rehabilitation for medical condition

3.3

7.0

X59

ICD-10 Finland

Exposure to unspecified factor

1.4

7.0

326

2429

V03AE02

ATC

sevelamer; oral

4.4

7.0

G62.1

ICD-10 Finland

Alcoholic polyneuropathy

6.3

6.9

N06AA09

ATC

amitriptyline; systemic

1.6

6.9

169

1104

UGC12

NOMESCO Finland

Flexible bronchoscopy

1.6

6.9

155

992

JJ1CE

NOMESCO Finland

Liver, bile duct and pancreas endoscopic ultrasound examination

5.5

6.9

J94.9

ICD-10 Finland

Pleural condition, unspecified

5.5

6.9

D51.9

ICD-10 Finland

Vitamin B12deficiency anaemia, unspecified

3.1

6.9

J04AB02

ATC

rifampicin; systemic

2.9

6.9

103

C02LM02, ,

ATC

2.9

6.9

103

Z01.6

ICD-10 Finland

Radiological examination, not elsewhere classified

1.6

6.9

169

1107

KA3AT

NOMESCO Finland

Biopsy of kidney with ultrasound guidance

2.8

6.9

114

WX722

NOMESCO Finland

PEEP

1.8

6.8

548

742, ,

NOMESCO Finland

8.3

6.8

F10.41

ICD-10 Finland

Withdrawal symptoms and delirium caused by alcohol with seizures

8.3

6.8

SPAT1144

SPAT

Treatment of reopened or infected surgical wound

1.7

6.8

135

838

207

Kela drug reimbursment

Chronic arrhythmias

1.4

6.8

321

2394

J96.0

ICD-10 Finland

Acute respiratory failure

2.9

6.8

109

SPAT1172

SPAT

Guidance concerning hydration

2.4

6.8

179

F60.2

ICD-10 Finland

Dissocial personality disorder

9.3

6.8

B25.8

ICD-10 Finland

Other cytomegaloviral diseases

9.3

6.8

W19

ICD-10 Finland

Unspecified fall

1.6

6.8

170

1118

K23.8*B37.8

ICD-10 Finland

Esophagitis caused by candidiasis

6.1

6.8

JJA43

NOMESCO Finland

Destruction of lesion of liver

40.2

6.8

2BB01, ,

NOMESCO Finland

40.2

6.8

Z51.4

ICD-10 Finland

Preparatory care for subsequent treatment, not elsewhere classified

3.6

6.8

K29.1

ICD-10 Finland

Other acute gastritis

2.9

6.7

104

F43.22

ICD-10 Finland

Adaptation disorder with mixed anxiety and depression

2.2

6.7

256

WX110

NOMESCO Finland

Infiltration anesthesia

1.3

6.7

1254

11316

SPAT1104

SPAT

Monitoring of emergency patient

1.7

6.7

121

733

57309

ICD-8 Finland

Other diseases of liver, Unspecified

7.2

6.7

D12.0

ICD-10 Finland

Benign neoplasm: Caecum

2.2

6.7

250

D10

ICPC

Vomiting

2.1

6.7

310

A41.2

ICD-10 Finland

Sepsis due to unspecified staphylococcus

22.6

6.7

N03AX14

ATC

levetiracetam; systemic

2.2

6.7

257

R19.8

ICD-10 Finland

Other specified symptoms and signs involving the digestive system and abdomen

3.0

6.7

JKA21

NOMESCO Finland

Laparoscopic cholecystectomy

1.5

6.6

182

1221

NG4AA

NOMESCO Finland

Lower leg X-ray examination

2.1

6.6

284

TNE25

NOMESCO Finland

Drill biopsy of bone marrow, pelvis

3.1

6.6

NHQ40

NOMESCO Finland

Amputation of toe

2.5

6.6

151

SPAT1211

SPAT

Application of soft bandage

1.6

6.6

151

972

Z53.0

ICD-10 Finland

Procedure not carried out because of contraindication

8.7

6.5

E13.8

ICD-10 Finland

Other specified diabetes mellitus, with unspecified complications

8.7

6.5

N06AB06

ATC

sertraline; oral

1.6

6.5

157

1022

NA1AD

NOMESCO Finland

Cervical spine CT examination

1.9

6.5

468

M00.0

ICD-10 Finland

Staphylococcal arthritis and polyarthritis

10.1

6.5

L04AA32

ATC

apremilast; oral

10.1

6.5

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

1.4

6.5

319

2394

L43.8

ICD-10 Finland

Other lichen planus

2.6

6.5

135

JKE32

NOMESCO Finland

Endoscopic dilatation of bile duct

6.2

6.5

JKE22

NOMESCO Finland

Endoscopic extraction of foreign body from bile duct

6.2

6.5

JF1CG

NOMESCO Finland

Extensive MRI of small bowel

5.7

6.4

K26.7

ICD-10 Finland

Duodenal ulcer, chronic without haemorrhage or perforation

5.7

6.4

S32.0

ICD-10 Finland

Fracture of lumbar vertebra

2.0

6.4

342

A10BD08

ATC

metformin and vildagliptin; systemic

3.2

6.4

T82

ICPC

Obesity

2.1

6.4

274

EB1JA

NOMESCO Finland

Double panorama tomography of teeth and jaws or similar X-ray examination

3.9

6.4

SPAT1122

SPAT

Ascites puncture

70.1

6.4

B16.9

ICD-10 Finland

Acute hepatitis B without delta-agent and without hepatic coma

70.1

6.4

L04AA18

ATC

[U] everolimus

70.1

6.4

JCA35

NOMESCO Finland

Endoscopic contact coagulation in oesophagus

70.1

6.4

A02BA03

ATC

famotidine; systemic

1.9

6.4

392

XFP02, ,

NOMESCO Finland

14.3

6.4

K51.0

ICD-10 Finland

Ulcerative (chronic) pancolitis

3.8

6.4

J01CE08

ATC

benzathine benzylpenicillin; parenteral

3.0

6.3

G03FA01

ATC

norethisterone and estrogen; systemic

0.5

6.3

1272

176

Kela drug reimbursment

Regorafenib

6.6

6.3

M14.6*E11.6

ICD-10 Finland

Non-insulin-dependent diabetes mellitus - Diabetic neuropathic

6.6

6.3

XF612

NOMESCO Finland

Measurement of central venous pressure

8.2

6.3

N12

ICD-10 Finland

Tubulo-interstitial nephritis, not specified as acute or chronic

2.7

6.3

125

N02AC04

ATC

dextropropoxyphene; oral

1.9

6.3

387

RJ421, ,

NOMESCO Finland

6.0

6.3

C08CA02

ATC

felodipine; oral

1.5

6.3

182

1236

XX4BW, ,

NOMESCO Finland

9.3

6.3

N06AB05

ATC

paroxetine; oral

1.8

6.3

504

ZXF05

NOMESCO Finland

Interruption of procedure for other patient related reason

3.9

6.3

B18.9

ICD-10 Finland

Chronic viral hepatitis, unspecified

+∞

6.3

5710A

ICD-9 Finland

Chronic liver disease and cirrhosis, Alcoholic fatty liver

+∞

6.3

3043A

ICD-9 Finland

Drug dependence, Cannabis dependence

+∞

6.3

5714X

ICD-9 Finland

Chronic liver disease and cirrhosis, Chronic hepatitis[HEPATITIS CHRONICA ALIA SEU NUD]

+∞

6.3

PH3YT

NOMESCO Finland

Insertion of catheter from portal vein to liver vein (TIPS)

+∞

6.3

5711A

ICD-9 Finland

Chronic liver disease and cirrhosis, Acute alcoholic hepatitis

+∞

6.3

D06AX11

ATC

rifaximin; topical

+∞

6.3

K04.5

ICD-10 Finland

Chronic apical periodontitis

1.3

6.2

477

3833

EBA30

NOMESCO Finland

Extraction of root of tooth

1.7

6.2

113

686

5718X

ICD-9 Finland

Chronic liver disease and cirrhosis, Other chronic nonalcoholic liver disease

26.8

6.2

A40.1

ICD-10 Finland

Sepsis due to streptococcus, group B

7.0

6.2

XX2RW, ,

NOMESCO Finland

3.1

6.2

EB1CI

NOMESCO Finland

Cone beam imaging of teeth and jaws (3-4 quarters)

3.1

6.2

R79.8

ICD-10 Finland

Other specified abnormal findings of blood chemistry

4.0

6.2

C07AA07

ATC

sotalol; systemic

1.9

6.2

376

SPF00

NOMESCO Finland

Reparation of dental prosthesis without impressions

2.1

6.2

279

SAA04

NOMESCO Finland

Special examination of mouth

1.8

6.1

507

JF1AB

NOMESCO Finland

Passage examination of small bowell with X-ray

2.6

6.1

133

SPAT1260

SPAT

Consultation of another employee

1.4

6.1

301

2260

SPAT1054

SPAT

Examination of peripheral nervous system

2.5

6.1

151

F41.09

ICD-10 Finland

UNS Panic Syndrome

2.5

6.1

145

Z50.8

ICD-10 Finland

Care involving use of other rehabilitation procedures

1.7

6.1

120

744

J01MA14

ATC

moxifloxacin; systemic

1.5

6.1

166

1112

R01AD59

ATC

mometasone, combinations; nasal

0.2

6.1

294

KA2AE

NOMESCO Finland

Ultrasound examination transplanted kidney

3.8

6.1

A02BD07

ATC

lansoprazole, amoxicillin and clarithromycin; systemic

1.8

6.1

546

JJB71

NOMESCO Finland

Laparoscopic resection of liver

12.6

6.1

F11.20

ICD-10 Finland

Addiction-induced dependence caused by opiates currently independent

12.6

6.1

WX199

NOMESCO Finland

Other local analgesia

1.9

6.1

350

IAA01

NOMESCO Finland

Assessment of need for psychiatric treatment

2.6

6.0

134

QDB10, ,

SPAT

2.5

6.0

152

R79.9

ICD-10 Finland

Abnormal finding of blood chemistry, unspecified

3.6

6.0

WPB10

NOMESCO Finland

Making a convalescent care decision

6.7

6.0

IAB10

NOMESCO Finland

Psychiatric consultation concerning substance abuse

10.0

6.0

D07AC13

ATC

mometasone; topical

1.3

6.0

492

3988

LabWAS

↥

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3023183) Ammonium ion [Moles/volume] in Plasma

839

332

42.46

307.65

5.9

1.9

46.20

34.58

umol/l

3.56

804

291

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

372

105

43.18

307.65

1.3

1.2

—

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

927

1892

8.19

307.65

8.1

2.7

16.57

8.36

umol/l

12.27

866

1672

(3033799) Differential panel - Peritoneal fluid

310

126.05

307.65

2.4

1.8

—

(3026692) Albumin [Mass/volume] in Peritoneal fluid

279

119.69

307.65

1.7

1.1

10.95

16.28

g/l

1.98

202

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

550

188

39.80

307.65

1.2

1.1

1.65

1.51

g/l

4.28

505

174

(3028026) IgM [Mass/volume] in Serum or Plasma

966

936

18.83

307.65

1.5

1.9

1.50

1.39

g/l

0.48

895

854

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

1292

1635

20.08

307.65

5.1

2.0

0.16

0.21

g/l

84.17

1173

1526

(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma

355

47.10

307.65

1.1

1.0

285.22

288.22

mg/l

0.13

322

(40768441) Liver Pathology biopsy report

313

102

36.12

307.65

2.2

1.2

—

(3022948) Iron [Moles/volume] in Serum or Plasma

1132

2747

8.08

307.65

3.4

2.6

12.74

12.93

umol/l

0.31

1079

2573

(3023487) Leukocytes [#/volume] in Peritoneal fluid

322

98.00

307.65

2.6

2.1

392.43

1059.97

e6/l

1.47

224

(3034770) Mitochondria Ab [Titer] in Serum

932

346

49.07

307.65

1.3

1.2

879.44

1920.00

titre

—

(4281824) Cell count and differential, peritoneal fluid

251

125

22.78

307.65

1.4

1.1

—

(3037522) Nuclear Ab [Titer] in Serum

999

1967

9.05

307.65

1.5

1.3

480.49

551.93

titre

0.52

243

436

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

813

1740

7.14

307.65

2.4

1.8

1.68

1.55

4.39

679

1501

(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma

754

194

61.35

307.65

3.6

2.1

1694.71

209.54

u/ml

0.62

740

189

(3009613) Erythrocytes [#/volume] in Peritoneal fluid

289

96.16

307.65

2.5

1.7

12276.43

4185.04

e6/l

0.57

157

(3017143) Hepatitis C virus Ab [Presence] in Serum

959

1452

11.65

307.65

1.6

—

(3024561) Albumin [Mass/volume] in Serum or Plasma

1677

7624

8.00

307.65

14.0

4.8

31.69

35.23

g/l

97.57

1644

7088

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

1427

5344

6.66

307.65

9.6

3.1

52.39

36.85

u/l

5.46

1391

5080

(44816559) Phosphatidylethanol [Mass/volume] in Blood

422

242

21.77

307.65

1.9

1.2

—

(3004789) Transferrin [Mass/volume] in Serum or Plasma

1107

2536

8.43

307.65

3.3

2.6

2.29

g/l

0.02

1039

2366

(3044007) Cell count panel - Peritoneal fluid

258

98.42

307.65

2.3

1.9

—

(3007164) IgA [Mass/volume] in Serum or Plasma

1031

2842

6.36

307.65

1.8

1.5

4.49

2.49

g/l

68.72

906

1686

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

1025

1528

12.56

307.65

1.6

1.5

—

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

367

364

12.09

307.65

1.3

1.4

—

(3005719) IgG [Mass/volume] in Serum or Plasma

1017

1210

15.88

307.65

2.2

3.0

13.63

10.43

g/l

43.44

952

1108

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

1099

2402

8.82

307.65

3.4

2.7

24.22

22.79

1.54

988

2056

(3007566) Smooth muscle Ab [Titer] in Serum

952

344

51.36

307.65

1.3

1.2

90.00

87.92

titre

0.04

(3020779) Urea [Moles/volume] in Serum or Plasma

722

1727

5.94

301.67

12.5

7.3

11.61

10.17

mmol/l

4.53

703

1640

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

225

121

20.80

289.12

1.3

1.2

247.00

119.23

titre

0.79

(3016650) Hepatitis A virus Ab [Presence] in Serum

268

215

14.21

279.64

1.1

—

(3021879) Hepatitis B virus core Ab [Presence] in Serum

504

951

6.73

267.90

1.4

1.5

—

(3006922) Hepatitis E virus Ab [Presence] in Serum

190

25.16

265.90

1.1

—

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

263

229

13.05

260.63

1.1

—

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

1714

9074

6.80

255.35

20.0

6.2

24.40

11.58

umol/l

45.43

1694

8631

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

181

25.39

254.49

1.1

1.0

—

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

181

25.39

254.49

1.1

1.0

—

(3042936) Bacteria identified in Isolate by Culture

818

2566

4.67

239.64

3.2

2.0

—

(3022217) INR in Platelet poor plasma by Coagulation assay

1639

8632

5.72

237.50

27.6

16.5

1.36

1.31

inr

1.47

497

2421

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

139

48.07

237.42

3.8

1.8

—

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

250

237

11.89

233.93

1.2

—

(3033658) Prothrombin time (PT) actual/Normal

1107

4427

4.31

231.67

15.1

3.9

67.14

87.27

104.28

1076

4328

(3001122) Ferritin [Mass/volume] in Serum or Plasma

1380

6524

4.51

226.76

4.9

2.8

201.98

157.27

ug/l

4.02

1324

5954

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

342

508

7.90

225.98

2.2

1.7

—

(3003458) Phosphate [Moles/volume] in Serum or Plasma

768

2400

4.55

223.93

8.8

6.1

1.10

1.04

mmol/l

5.65

726

2221

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

1082

4349

4.20

222.67

3.6

2.2

3.91

2.99

mg/l

17.02

991

3682

(3012095) Magnesium [Moles/volume] in Serum or Plasma

859

2948

4.32

220.19

5.1

3.4

0.77

0.82

mmol/l

21.65

817

2775

(40768797) Stomach Pathology biopsy report

736

2383

4.28

201.69

1.4

1.2

—

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

691

2138

4.39

201.35

3.4

4.3

239.84

249.23

u/l

0.88

671

2031

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

372

694

6.34

196.77

3.1

3.4

104.05

6019.64

u/ml

0.86

332

593

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

1177

5421

3.80

189.78

4.9

2.5

59.88

74.97

u/l

0.49

1131

4997

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

403

873

5.52

180.85

2.1

1.8

1.00

1.56

g/l

23.58

341

759

(3018677) aPTT in Platelet poor plasma by Coagulation assay

785

2856

3.86

178.98

3.1

2.1

32.58

29.87

20.33

757

2771

(3027945) Reticulocytes/100 erythrocytes in Blood

669

2182

4.09

178.64

3.2

2.5

2.32

1.77

17.78

613

1932

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

132

22.34

177.51

4.7

2.3

—

(3012544) pH of Venous blood

599

1824

4.24

175.62

6.1

3.8

7.40

7.39

—

(3021447) Carbon dioxide [Partial pressure] in Venous blood

582

1764

4.23

171.29

6.1

3.8

5.54

5.85

kpa

8.95

568

1705

(3002032) Base excess in Venous blood by calculation

580

1764

4.21

169.74

6.2

3.8

1.15

1.96

mmol/l

4.14

471

1475

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

224

297

8.36

161.74

1.4

1.2

—

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

228

311

8.13

160.70

1.5

—

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

216

277

8.61

160.31

1.4

1.2

338.94

275.95

u/ml

1.33

128

160

(3023368) Bacteria identified in Blood by Culture

1084

5116

3.41

160.27

7.0

4.5

—

(3042733) HLA Ab [Presence] in Serum

113

25.41

160.24

1.7

5.5

—

(3026250) Tacrolimus [Mass/volume] in Blood

124

20.26

160.02

34.6

31.0

7.34

7.02

ug/l

0.64

110

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

598

1938

3.96

158.98

3.3

4.2

4.92

22.37

ug/l

2.74

522

1609

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

238

353

7.51

155.76

7.8

5.0

712.37

660.51

iu/ml

0.04

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

379

887

5.03

154.21

5.7

4.2

23.13

24.15

mmol/l

5.78

372

868

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

272

476

6.45

152.04

5.4

3.7

1.84

1.62

mg/l

3.39

258

432

(3000991) Gas panel - Venous blood

523

1598

4.06

150.34

12.3

8.7

—

(40760892) CBC W Ordered Manual Differential panel - Blood

1394

7912

3.45

146.93

10.5

6.4

—

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

206

278

8.14

146.25

1.4

1.5

123.19

122.35

u/ml

0.02

(3023520) Reticulocytes [#/volume] in Blood

522

1637

3.95

144.05

3.5

2.6

83.15

69.58

e9/l

8.37

406

1253

(3024471) HLA-A [Type]

106

21.88

141.77

1.0

—

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

770

3135

3.35

141.70

1.4

1.2

2.32

1.48

u/ml

0.71

154

823

(3024932) HLA-DR beta [Type]

105

22.09

141.03

1.0

1.1

—

(3048929) Epstein Barr virus Ab [Presence] in Serum

238

396

6.68

139.50

1.4

1.3

—

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

500

1583

3.87

135.34

4.1

2.4

28.97

68.91

u/l

0.74

446

1361

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

144

134

11.49

135.27

1.1

1.0

—

(3006315) Basophils [#/volume] in Blood

1411

8401

3.24

130.20

9.8

5.8

0.04

e9/l

1.98

1234

7239

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

1621

10498

3.73

129.53

11.7

3.1

181.34

52.55

u/l

97.29

1572

9683

(3001604) Monocytes [#/volume] in Blood

1407

8384

3.22

129.23

9.8

5.8

0.58

0.61

e9/l

2.29

1229

7225

(46235355) HIV 1 and 2 tests - Meaningful Use set

549

1905

3.58

128.90

1.7

1.6

—

(3019198) Lymphocytes [#/volume] in Blood

1425

8579

3.23

128.00

9.9

5.9

1.59

1.92

e9/l

4.19

1262

7569

(3044640) Blood type and Crossmatch panel - Blood

1066

5469

3.01

127.95

4.6

2.6

—

(3019069) Monocytes/100 leukocytes in Blood

1350

7904

3.13

126.98

10.7

6.5

9.62

8.86

12.65

1298

7375

(3022096) Basophils/100 leukocytes in Blood

1318

7634

3.08

126.01

10.3

6.2

0.70

0.67

1.48

1264

7111

(3020630) Protein [Mass/volume] in Serum or Plasma

478

1539

3.76

125.41

2.0

2.8

66.27

66.33

g/l

0.05

451

1404

(3006504) Eosinophils/100 leukocytes in Blood

1342

7865

3.10

125.33

10.3

6.1

2.97

2.87

0.86

1290

7331

(3002030) Lymphocytes/100 leukocytes in Blood

1360

8052

3.10

124.25

10.6

6.2

24.14

27.05

18.06

1307

7539

(3013115) Eosinophils [#/volume] in Blood

1423

8681

3.15

122.39

10.2

6.1

0.18

0.20

e9/l

3.95

1253

7602

(3018010) Neutrophils/100 leukocytes in Blood

1337

7930

3.02

120.02

10.2

6.0

59.38

57.67

5.60

1287

7418

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

1418

8764

3.06

116.50

14.0

7.2

1.19

1.21

mmol/l

28.65

1249

7426

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

102

14.66

112.32

1.9

1.3

—

(3014111) Lactate [Moles/volume] in Serum or Plasma

480

1663

3.47

111.40

10.7

7.4

1.88

1.39

mmol/l

8.34

468

1622

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

130

139

9.93

110.55

1.2

—

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

131

142

9.79

110.28

2.3

—

(3010375) cycloSPORINE [Mass/volume] in Blood

101

14.31

109.73

35.3

26.8

133.12

120.71

ug/l

0.65

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

408

1288

3.71

109.06

2.1

1.6

—

(3024980) IgG subclass 4 [Mass/volume] in Serum

162

234

7.44

107.84

1.5

1.6

1.02

0.87

g/l

0.58

139

171

(3013650) Neutrophils [#/volume] in Blood by Automated count

1498

9795

3.04

106.12

13.4

9.2

3.88

4.20

e9/l

4.52

1348

8558

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

172

271

6.84

105.65

2.3

3.0

1183.13

1921.42

u/ml

—

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

859

4248

2.78

105.20

4.3

2.5

—

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

1314

8048

2.80

104.99

12.2

6.4

1.18

1.21

mmol/l

33.76

1260

7312

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

224

460

5.35

104.57

1.8

1.5

—

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

209

409

5.58

102.89

2.6

3.4

3005.62

1009.52

u/ml

0.31

196

379

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

220

475

5.07

96.78

2.9

2.4

221.02

198.57

2.60

215

453

(3018418) pH of Serum or Plasma

960

5190

2.62

96.06

6.6

4.2

7.41

7.40

1.04

212

995

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

161

262

6.59

95.73

1.4

1.2

—

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

105

107

10.30

92.30

1.2

—

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

536

2213

2.93

90.34

11.0

7.9

4.83

5.11

kpa

7.27

517

2114

(3027801) Oxygen [Partial pressure] in Arterial blood

536

2214

2.93

90.26

11.0

7.9

11.60

11.95

kpa

1.01

518

2116

(3024354) Oxygen [Partial pressure] in Venous blood

409

1453

3.27

89.53

5.4

3.1

4.81

4.54

kpa

1.52

392

1402

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

642

2997

2.67

84.70

2.2

1.9

—

(3036489) Thrombin time

243

632

4.23

84.39

2.7

2.1

24.55

21.53

6.12

232

574

(3016502) Oxygen saturation in Arterial blood

492

2019

2.90

83.11

11.5

8.2

95.45

95.54

0.10

481

1943

(3013826) Glucose [Moles/volume] in Serum or Plasma

1493

10384

2.67

82.18

12.0

5.0

7.86

6.82

mmol/l

33.39

1456

9807

(3020682) Albumin/Creatinine [Ratio] in Urine

1008

5874

2.43

81.96

4.6

3.8

15.82

8.11

mg/mmol

3.89

742

3780

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

252

689

4.04

81.68

3.7

2.9

0.27

0.34

u/ml

3.79

144

391

(3003396) Base excess in Arterial blood by calculation

519

2213

2.81

81.38

11.2

7.9

-0.13

1.10

mmol/l

6.59

423

1759

(3002582) Erythrocytes [#/volume] in Urine

946

5377

2.43

81.13

4.4

3.4

54.07

80.77

e6/l

0.88

753

4203

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

311

989

3.53

80.77

13.1

10.3

23.48

24.35

mmol/l

3.80

300

966

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

612

2847

2.65

80.73

3.5

3.1

2.51

1.79

e6/l

1.16

357

1600

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

1246

8050

2.43

79.18

4.9

2.7

—

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

116

163

7.49

78.86

1.3

1.2

46.70

57.50

u/l

0.97

111

150

(3030467) Casts [#/volume] in Urine by Automated count

882

4919

2.41

78.19

4.2

3.2

0.80

0.41

e6/l

3.69

706

3803

(3026782) Osmolality of Urine

707

3574

2.50

77.88

3.8

3.0

516.09

553.62

mosm/kgh2o

4.67

631

3068

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

18.03

77.68

1.1

1.0

—

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

17.36

77.47

1.1

1.0

—

(3009508) Creatinine [Moles/volume] in Urine

981

5759

2.37

76.99

4.1

3.2

7.05

7.75

mmol/l

5.58

827

4831

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

1740

13293

3.20

76.18

24.1

7.6

126.78

78.61

u/l

112.57

1714

12538

(3019309) Folate [Moles/volume] in Red Blood Cells

679

3401

2.50

75.97

2.0

1.8

1246.94

1168.70

nmol/l

1.12

552

2571

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

330

1153

3.22

73.30

4.8

3.7

0.95

1.89

mmol/l

2.59

225

856

(3002173) Hemoglobin [Mass/volume] in Arterial blood

448

1860

2.81

73.11

12.4

8.5

110.98

122.23

g/l

20.56

443

1804

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

341

1220

3.16

72.75

4.9

3.7

4.84

5.16

kpa

8.01

330

1164

(3009343) pH of Capillary blood

338

1204

3.17

72.64

4.8

3.7

7.42

7.41

0.65

153

(3012516) Albumin [Mass/volume] in Urine

948

5585

2.31

72.52

3.8

3.3

305.01

267.27

mg/l

0.13

702

3634

(3018095) Leukocytes [#/volume] in Urine

1010

6140

2.29

71.31

5.1

3.8

108.72

111.32

e6/l

0.04

782

4498

(3021960) Folate [Moles/volume] in Serum or Plasma

773

4206

2.36

70.90

2.0

1.6

18.59

20.34

nmol/l

2.70

705

3572

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

203

524

4.19

70.87

1.3

—

(3026493) Urate [Moles/volume] in Serum or Plasma

843

4768

2.32

70.53

4.2

2.9

5519.43

5635.53

umol/l

0.02

751

4142

(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood

339

1244

3.07

69.01

13.5

9.3

1.51

1.35

2.83

339

1234

(3006217) Methemoglobin/Hemoglobin.total in Arterial blood

337

1235

3.07

68.75

13.8

9.4

0.64

0.67

0.80

337

1223

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

613

3055

2.44

68.12

3.3

2.9

1.37

1.01

e6/l

1.64

357

1802

(3004588) Protein electrophoresis panel - Serum or Plasma

348

1306

3.01

68.03

1.7

2.6

—

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

1125

7257

2.24

67.40

2.6

2.0

92.46

93.83

pmol/l

0.37

620

3841

(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum

184

465

4.25

65.97

1.5

1.2

7.24

9.51

iu/ml

—

(36304419) Bacteria [Presence] in Urine

826

4766

2.24

64.44

4.2

3.2

—

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

465

2091

2.59

63.91

2.0

1.7

—

(3026008) Bacteria identified in Urine by Culture

851

5046

2.18

61.23

4.0

3.2

—

(3009445) Proteinase 3 Ab [Units/volume] in Serum

240

768

3.41

61.01

1.6

17.74

24.12

u/ml

0.21

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

458

2088

2.54

60.86

2.1

1.8

—

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

907

5540

2.15

60.21

4.0

3.1

2057.22

1458.42

ng/l

2.41

823

4769

(3007853) Bacteria identified in Skin by Aerobe culture

440

2005

2.53

58.27

2.2

1.7

—

(3000093) Morphology [Interpretation] in Blood Narrative

101

179

5.89

54.82

1.2

1.1

—

(3021589) Normoblasts [#/volume] in Blood

1097

7419

2.05

53.20

20.7

9.9

0.00

e9/l

0.55

919

6072

(3002179) Metamyelocytes/100 leukocytes in Blood

326

1337

2.71

53.17

5.1

4.1

0.86

0.68

0.30

155

473

(3017181) Myelocytes/100 leukocytes in Blood

348

1477

2.64

53.00

5.3

4.2

0.74

0.87

0.63

173

556

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

291

1128

2.85

52.87

1.9

1.6

—

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

196

605

3.48

52.50

1.6

131.43

310.00

titre

—

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

232

810

3.11

50.77

2.3

2.0

2.87

1.93

ug/l

0.60

210

722

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

406

1900

2.42

50.04

4.5

3.5

—

(3034274) Bile acid [Moles/volume] in Serum --fasting

9.22

50.01

3.2

1.6

32.14

9.33

umol/l

3.49

(3003181) Sodium [Moles/volume] in Urine

126

302

4.38

48.20

1.4

1.3

47.31

63.06

mmol/l

4.34

250

(40758558) Short blood count panel - Blood

720

4300

2.05

48.06

10.0

6.8

—

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

211

719

3.16

48.04

1.6

2.7

6.94

7.36

g/l

3.05

194

653

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

213

730

3.14

48.03

2.1

1.9

48.70

38.32

u/l

5.19

188

631

(3021440) Promyelocytes/100 leukocytes in Blood

324

1396

2.57

47.51

5.4

4.3

0.06

0.12

1.24

151

476

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

210

719

3.14

47.41

1.6

2.7

—

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

191

618

3.31

47.36

1.7

3.9

60.66

72.54

mg/l

0.23

153

505

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

267

1050

2.78

46.94

14.4

10.9

—

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

209

719

3.13

46.79

1.6

2.7

4.48

3.62

g/l

8.66

193

653

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

187

602

3.32

46.74

1.7

3.9

1.98

2.95

ratio

0.31

(3034860) Kappa light chains.free [Mass/volume] in Serum

190

618

3.29

46.70

1.7

3.9

80.69

61.87

mg/l

0.91

152

503

(3022313) Gas panel - Capillary blood

236

873

2.93

46.49

5.1

3.8

—

(3000850) Epithelial cells [#/volume] in Urine

652

3793

2.06

46.47

3.3

2.6

6.59

4.74

e6/l

2.29

602

3413

(3027273) Bicarbonate [Moles/volume] in Venous blood

244

925

2.86

45.93

6.0

3.2

24.28

25.20

mmol/l

2.57

239

890

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

981

6604

1.94

45.73

3.4

2.2

71.54

77.66

nmol/l

8.39

914

5845

(3037756) Immunofixation for Serum or Plasma

147

410

3.79

45.72

1.2

1.8

—

(4035726) Immunohistochemistry procedure

342

1542

2.47

45.40

1.7

1.4

—

(3004119) Hemoglobin [Mass/volume] in Venous blood

286

1188

2.64

45.07

6.3

3.2

112.47

129.06

g/l

24.89

281

1157

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

620

3607

2.04

43.70

2.2

1.7

2.53

1.31

mg/l

6.59

546

2808

(3025159) Blasts/100 leukocytes in Blood

302

1307

2.54

43.66

5.3

4.4

0.54

0.33

0.16

125

386

(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing

58.07

43.55

1.2

—

(3003434) Protein [Mass/volume] in Pleural fluid

111

264

4.39

42.85

1.8

1.5

27.77

32.67

g/l

2.80

100

236

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

195

679

3.07

42.66

1.6

2.7

14.40

10.19

g/l

14.22

178

610

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

266

1095

2.65

42.57

1.6

1.5

—

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

135

373

3.81

42.53

1.6

—

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

191

668

3.05

41.44

1.6

2.7

3.02

2.96

g/l

0.36

175

602

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

6.82

41.31

1.8

1.6

12.57

5.73

u/l

1.13

(3000012) Reticulocyte production index

110

268

4.28

41.15

3.1

2.3

—

(40760888) Immunoglobulin light chains.free panel - Serum

151

462

3.45

40.82

1.7

4.1

—

(3031040) Bacteria [#/volume] in Urine by Automated count

1416

11002

1.96

40.53

6.1

4.5

532.14

1644.96

e6/l

1.04

173

(1616796) Gas panel - Central venous blood

137

404

3.56

39.17

4.1

4.3

—

(3020191) Ethanol [Moles/volume] in Serum or Plasma

117

6.07

39.14

1.3

1.2

0.65

1.28

promille

2.65

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

184

656

2.99

38.53

2.5

2.3

1193.69

526.84

ug/l

1.26

172

621

(3042111) Morphology [Interpretation] in Bone marrow Narrative

122

337

3.79

38.41

1.6

—

(3021901) Oxygen saturation in Capillary blood

127

361

3.69

38.35

3.2

2.8

—

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

138

416

3.49

38.15

1.4

1.5

—

(3012441) Differential panel - Pleural fluid

204

4.62

37.82

1.8

1.5

—

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

618

3761

1.93

37.17

1.9

1.7

512.19

29531271.37

pmol/l

3.01

526

3112

(36660697) Celiac disease serology panel - Serum

259

1123

2.50

36.99

1.2

—

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

161

545

3.12

36.87

1.6

2.6

0.03

g/l

0.12

147

502

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

174

618

2.99

36.65

1.7

2.8

0.84

1.35

g/l

0.85

154

539

(3036481) Cortisol [Moles/volume] in Serum or Plasma

312

1479

2.31

36.47

2.1

2.2

350.26

369.70

nmol/l

0.53

299

1358

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

152

517

3.10

34.49

1.6

2.6

0.01

0.00

g/l

0.50

138

475

(3023199) Leukocytes [#/volume] in Pleural fluid

242

4.07

33.48

1.9

1.4

1322.04

1633.07

e6/l

0.46

180

(3022145) Colonoscopy Study observation

361

1876

2.12

33.43

1.5

1.3

—

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

149

512

3.06

33.21

1.6

2.6

0.00

g/l

-0.00

136

474

(3037467) Urinalysis macro (dipstick) panel - Urine

1431

11499

1.83

32.71

6.1

4.3

—

(3000494) Fungus identified in Specimen by Culture

380

2031

2.07

32.59

2.0

1.4

—

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

279

1320

2.29

32.56

6.1

4.1

114.83

95.75

ng/l

1.71

249

1145

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

270

3.80

31.72

7.7

6.8

12.59

11.90

mg/l

0.68

251

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

157

571

2.90

31.61

1.6

2.5

34.45

37.55

g/l

6.90

141

504

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

8.66

31.43

1.8

1.3

12.81

8.71

ug/l

2.83

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

186

742

2.66

31.39

5.8

4.0

23.57

24.95

mmol/l

5.45

176

690

(40759836) Histone Ab [Presence] in Serum by Immunoblot

111

5.54

31.09

1.1

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

111

5.54

31.09

1.1

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

111

5.54

31.09

1.1

—

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

119

372

3.34

31.02

1.2

1.6

0.91

0.80

nmol/l

0.80

312

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

114

5.39

30.20

1.1

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

114

5.39

30.20

1.1

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

114

5.39

30.20

1.1

—

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

565

3536

1.83

30.02

4.5

4.0

560.78

721.19

ng/l

0.21

476

2929

(3013707) Erythrocyte sedimentation rate by Westergren method

1506

12434

1.83

29.77

6.7

4.1

25.10

12.65

mm/h

76.34

1417

11460

(40768806) Pleura Pathology biopsy report

205

4.13

29.63

1.8

1.6

—

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

317

1638

2.11

29.53

4.2

2.9

275.56

213.56

ng/l

1.51

296

1506

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

150

4.66

28.83

1.6

1.4

—

(3028308) Erythrocytes [#/volume] in Pleural fluid

215

3.98

28.59

1.9

1.4

20673.12

93951.44

e6/l

1.54

133

(3045788) Cell count panel - Pleural fluid

193

4.16

28.58

1.9

1.4

—

(3012501) Base excess in Blood by calculation

121

403

3.13

28.41

5.5

5.2

2.28

2.70

mmol/l

0.79

275

(3029075) Extractable nuclear Ab panel - Serum

8.05

28.17

1.0

—

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

6.10

28.16

2.8

2.0

—

(3024928) Oxygen saturation in Venous blood

122

411

3.09

28.10

5.2

3.1

—

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

291

1482

2.13

28.08

3.3

2.8

54.33

64.39

ml/min/173m2

2.78

130

595

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

166

661

2.65

28.06

2.4

2.7

—

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

135

489

2.89

27.35

1.3

1.7

—

(3027923) C peptide [Moles/volume] in Serum or Plasma

100

5.42

26.89

1.3

1.25

1.09

nmol/l

0.52

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

280

1437

2.10

26.39

5.7

4.1

1.20

1.22

mmol/l

7.53

267

1253

(3004809) Band form neutrophils/100 leukocytes in Blood

101

316

3.31

26.29

3.3

3.8

1.35

1.51

0.19

281

(40767503) Oxygen content in Capillary blood by calculation

117

400

3.04

26.27

3.4

2.6

14.33

16.23

4.67

209

(3028192) IgG subclass 2 [Mass/volume] in Serum

146

4.49

26.04

1.2

1.3

3.29

2.78

g/l

1.05

(3024139) IgG subclass 3 [Mass/volume] in Serum

146

4.49

26.04

1.2

1.3

0.52

0.39

g/l

1.32

(3027135) IgG subclass 1 [Mass/volume] in Serum

146

4.49

26.04

1.2

1.3

10.69

6.65

g/l

3.58

(3010421) pH of Blood

130

479

2.83

25.51

5.7

4.9

7.42

0.17

119

430

(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma

5.70

25.27

1.1

51.34

20.29

u/l

3.24

(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma

5.70

25.27

1.1

141.12

74.64

u/l

3.30

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

127

467

2.83

25.01

1.3

1.5

1.08

1.17

g/l

2.04

118

447

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

123

447

2.87

24.75

1.3

1.5

0.20

0.24

g/l

4.71

114

429

(4062490) Immunoglobulin typing, IgG

148

4.36

24.71

1.2

1.3

—

(3019060) Gas panel - Arterial blood

258

1315

2.10

24.68

6.7

5.2

—

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

106

355

3.10

24.65

1.6

1.5

—

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

181

799

2.39

24.55

6.6

5.9

1.87

1.62

2.59

172

743

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

101

5.15

24.54

1.5

1.4

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

5.21

24.34

1.9

1.4

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

5.21

24.34

1.9

1.4

—

(3007930) Methemoglobin/Hemoglobin.total in Blood

176

788

2.35

23.10

6.8

5.9

0.84

0.89

0.85

168

733

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

100

5.00

22.79

1.5

1.4

—

(3039162) Centromere protein B Ab [Units/volume] in Serum

180

3.87

22.75

1.1

1.2

35.28

90.95

u/ml

—

(3022493) Free Hemoglobin [Mass/volume] in Plasma

5.71

22.14

1.5

4.4

58.45

78.23

mg/l

0.75

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

758

5496

1.61

21.95

2.7

2.2

262.79

252.10

u/l

0.09

725

5156

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

915

6944

1.58

21.77

5.6

3.8

47.01

55.13

ng/l

0.42

766

5175

(3035350) Ketones [Presence] in Urine by Test strip

1036

8094

1.57

21.69

4.8

3.7

0.00

estimate

0.30

242

1616

(3052851) Hemolysis interference index of Serum or Plasma

133

542

2.56

21.40

4.8

3.3

—

(3008152) Bicarbonate [Moles/volume] in Arterial blood

239

1249

2.04

21.25

10.0

7.3

23.43

24.61

mmol/l

3.61

234

1184

(3009261) Glucose [Presence] in Urine by Test strip

1039

8160

1.56

20.99

4.8

3.7

0.00

estimate

0.80

200

1453

(3021601) Nitrite [Presence] in Urine by Test strip

1028

8057

1.56

20.94

6.6

5.0

0.00

estimate

-0.00

229

1531

(3015377) Calcium [Moles/volume] in Serum or Plasma

791

5843

1.58

20.90

3.9

3.4

2.31

2.35

mmol/l

9.52

702

5107

(3015736) pH of Urine

857

6472

1.56

20.42

4.2

3.5

5.72

5.77

0.10

398

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

7.34

19.94

1.1

—

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

126

520

2.52

19.75

1.7

1.6

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

210

3.37

18.81

1.5

—

(3000570) Elastase.pancreatic [Mass/mass] in Stool

120

497

2.50

18.67

1.4

1.5

261.26

281.53

ug/g

0.41

308

(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection

5.87

18.39

2.9

2.2

63455.57

3773.70

u/ml

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

209

3.33

18.25

1.5

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

209

3.33

18.25

1.5

—

(3035880) pH of Pleural fluid

116

4.21

18.20

1.4

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

210

3.32

18.12

1.5

—

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

110

447

2.54

17.81

1.7

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

4.89

17.81

1.5

1.4

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

4.89

17.81

1.5

1.4

—

(3006184) Hemoglobin [Mass/volume] in Capillary blood

103

406

2.62

17.75

3.0

2.1

114.05

130.04

g/l

6.47

298

(3008838) Polymorphonuclear cells/100 leukocytes in Peritoneal fluid

+∞

17.73

1.8

0.0

28.20

—

(3014148) Varicella zoster virus Ab [Titer] in Serum

137

3.87

17.56

1.1

—

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

101

397

2.63

17.50

1.1

1.2

26.66

3.62

u/ml

0.75

(3009871) Measles virus Ab [Titer] in Serum

6.83

17.43

1.7

1.6

—

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

4.53

17.08

1.1

—

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

101

402

2.59

17.07

1.1

1.2

10.49

9.31

u/ml

0.05

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

208

3.25

17.03

1.5

—

(21494434) Karyotype in Bone marrow

198

3.31

17.02

1.1

1.2

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

209

3.23

16.90

1.5

—

(3028707) Methadone [Presence] in Urine by Screen method

132

3.86

16.84

5.8

1.7

—

(3037121) Protein [Mass/volume] in Urine

140

651

2.24

16.77

2.8

3.2

0.31

0.25

g/l

0.58

262

(3036180) Methadone [Presence] in Urine

6.30

16.75

9.4

1.6

—

(3033705) Calcium.ionized [Moles/volume] in Venous blood

219

3.13

16.29

3.7

2.6

—

(3011397) Hemoglobin [Presence] in Urine by Test strip

547

3887

1.56

16.24

4.0

3.7

—

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

275

2.87

16.04

1.1

1.3

192.73

197.14

miu/ml

0.03

101

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

102

421

2.50

16.00

1.1

1.2

16.74

41.03

u/ml

—

(3003694) ABO and Rh group [Type] in Blood

604

4402

1.53

15.94

1.6

1.3

—

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

114

499

2.36

15.73

2.3

2.2

127.97

102.96

ug/min

0.28

307

(3001893) Eosinophils/100 leukocytes in Pleural fluid

4.92

15.70

1.5

1.6

2.36

2.71

0.10

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

296

2.77

15.62

1.1

1.2

106.83

48.73

u/ml

—

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

4.79

15.20

1.1

1.6

86.00

100.71

umol/l

—

(3005532) Lymphocytes/100 leukocytes in Pleural fluid

4.56

15.19

1.5

1.6

63.90

60.11

0.23

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

325

2.65

15.05

1.6

1.8

—

(3017354) Segmented neutrophils/100 leukocytes in Blood

198

3.15

15.03

3.2

3.7

62.40

55.12

1.47

167

(3020891) Body temperature

156

796

2.04

14.71

8.0

4.6

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

383

2.50

14.67

1.5

1.3

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

383

2.50

14.67

1.5

1.3

—

(3051611) Lipemic interference index of Serum or Plasma

181

3.21

14.57

3.9

3.4

—

(21494890) Protein electrophoresis panel - 24 hour Urine

202

3.08

14.54

1.4

2.3

—

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

141

698

2.10

14.42

2.1

1.8

—

(3025941) Bacteria identified in Stool by Culture

163

851

2.00

14.42

1.3

—

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

100

431

2.39

14.30

1.7

—

(3051651) Icteric interference index of Serum or Plasma

111

3.84

14.16

3.9

3.7

—

(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection

30.25

13.88

2.7

3.2

—

(3042631) Mycobacterium sp identified in Specimen

278

2.69

13.52

2.3

2.6

—

(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay

164

3.23

13.46

1.2

—

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

147

763

2.00

13.22

2.4

1.9

—

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

166

3.19

13.20

1.1

—

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

265

2.70

13.12

1.5

1.6

—

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

189

3.02

12.95

3.8

2.5

—

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

267

2.68

12.93

1.1

223.71

66.01

iu/ml

—

(3043409) Potassium [Moles/volume] in Arterial blood

124

613

2.09

12.74

6.5

4.0

3.94

3.92

mmol/l

0.11

124

605

(3019225) pH of Specimen

278

1771

1.66

12.73

7.2

4.4

—

(21494755) Public health laboratory ask at order entry panel

1067

0.28

12.72

1.4

—

(3013512) EKG study

692

5383

1.43

12.50

5.6

4.0

—

(3008757) Leukocyte morphology finding [Identifier] in Blood

226

2.80

12.50

3.8

4.4

—

(3032035) Polymorphonuclear cells/100 leukocytes in Blood

330

2.45

12.13

4.6

3.6

57.10

58.05

0.25

330

(40768804) Tissue Pathology biopsy report

825

6647

1.41

12.12

2.6

2.2

—

(3020876) Protein [Mass/time] in 24 hour Urine

202

2.87

12.11

1.8

2.5

0.97

1.55

g/24h

0.80

100

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

1171

0.33

12.07

1.6

1.8

—

(3041678) Intrinsic coagulation system thromboelastography panel - Blood

21.41

12.01

1.4

1.1

—

(3000919) Neutrophils/100 leukocytes in Pleural fluid

4.38

11.70

1.3

1.5

20.50

28.99

0.72

(3048689) Calprotectin [Mass/mass] in Stool

266

1713

1.64

11.63

2.8

2.3

192.38

159.09

ug/g

0.67

224

1368

(3027456) Digoxin [Moles/volume] in Serum or Plasma

387

2.30

11.62

3.0

3.3

0.73

0.82

nmol/l

1.04

306

(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

12.61

11.62

1.0

—

(3004775) Volume in Urine collected for unspecified duration

153

3.12

11.58

2.2

2.3

737.55

645.60

0.50

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

101

483

2.15

11.33

1.6

0.23

13.36

iu/ml

0.49

(3044927) Protein electrophoresis panel - Urine

205

2.78

11.23

1.1

1.2

—

(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma

3.90

11.11

2.2

2.3

1436.69

1301.75

u/ml

0.13

(3028029) Mesothelial cells/100 leukocytes in Pleural fluid

8.60

11.02

1.4

1.9

20.64

4.86

1.49

(3040151) Glucose [Moles/volume] in Capillary blood

204

2.74

10.77

8.0

5.7

8.71

7.50

mmol/l

1.30

166

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

305

2.41

10.76

1.7

1.6

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

305

2.41

10.76

1.7

1.6

—

(3002256) Pathology report gross observation

325

2235

1.54

10.70

1.4

1.3

—

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

201

2.73

10.51

1.5

1.7

—

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

127

3.19

10.30

1.5

1.6

30.60

26.44

u/ml

—

(1001926) Buprenorphine [Presence] in Urine by Screen method

216

2.64

10.18

6.6

1.5

—

(3008295) Osmolality of Serum or Plasma

179

2.78

9.90

1.3

1.4

276.20

276.05

mosm/kgh2o

0.01

127

(1761482) Bacteria [#/volume] in Urine by Culture

463

2.08

9.80

6.3

4.6

—

(3011288) Drugs identified in Urine by Screen method

183

2.72

9.51

7.9

1.8

—

(3045142) Bone marrow Pathology biopsy report

230

2.52

9.48

1.4

1.3

—

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

517

6547

0.72

9.37

3.4

4.4

23.02

21.69

0.86

214

3278

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

112

602

1.91

9.15

2.3

3.6

215.43

71.82

u/ml

3.19

106

581

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

348

2.20

9.12

1.3

1.2

50.66

45.39

u/l

0.13

300

(3040491) Angiotensin converting enzyme [Enzymatic activity/volume] in Pleural fluid

7.98

8.85

1.1

1.3

13.21

23.06

u/l

0.75

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

146

2.85

8.71

1.5

1.7

—

(3017569) Oxygen content in Arterial blood

3.30

8.49

2.1

2.7

—

(3052318) Alpha-1-Microglobulin [Mass/volume] in Urine

7.37

8.44

2.1

2.5

58.12

32.94

mg/l

—

(3000492) Spirometry study

233

1566

1.55

8.44

1.4

1.5

—

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

435

3305

1.40

8.42

3.5

3.1

2.50

2.45

mmol/l

8.66

379

2905

(4146454) Self-monitoring of blood glucose

207

2.50

8.42

3.2

2.5

—

(3016879) Cocaine [Presence] in Urine

263

2.32

8.38

6.6

1.7

—

(3013945) Hepatitis B virus e Ab [Presence] in Serum

12.81

8.37

1.4

1.0

—

(3043410) Blood group antigens tested for on Red Blood Cells

4.00

8.34

1.7

2.0

—

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

1759

16545

1.48

8.08

43.0

15.5

22.58

25.78

mg/l

6.13

1687

13250

(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid

4.03

8.07

1.3

11.60

72.82

ug/l

—

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

294

2.22

8.02

4.5

3.7

—

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

6.30

8.01

1.1

—

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

745

0.33

7.86

1.4

1.5

—

(40768443) Skin Pathology biopsy report

127

746

1.75

7.82

1.2

—

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

4.07

7.80

1.3

1.2

—

(40768446) Kidney Pathology biopsy report

3.67

7.74

1.4

1.7

—

(3000764) Benzodiazepines [Presence] in Urine

279

2.22

7.73

6.5

1.6

—

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

4.35

7.68

1.3

1.2

—

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

326

2.12

7.67

1.6

1.5

—

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

3.36

7.66

2.3

2.4

—

(3028300) Cannabinoids [Presence] in Urine

281

2.21

7.61

7.2

1.6

—

(3027008) Opiates [Presence] in Urine

281

2.21

7.61

3.0

1.6

—

(40761539) Cells [Type] in Urine sediment by Light microscopy

4.25

7.48

1.1

—

(3047181) Lactate [Moles/volume] in Blood

108

614

1.80

7.44

8.6

7.1

1.99

1.35

mmol/l

1.98

536

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

364

4737

0.72

7.43

2.5

3.1

0.70

0.76

ug/l

0.65

249

3229

(3048879) Bone marrow aspiration report

3.76

7.36

1.2

1.9

—

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

259

2.24

7.36

1.5

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

221

2.34

7.35

1.6

1.3

—

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

292

2.16

7.33

1.5

—

(1761868) Lipid panel - Serum or Plasma

434

5477

0.74

7.25

4.2

3.1

—

(3035637) Corticotropin [Mass/volume] in Plasma

210

2.37

7.24

1.3

1.5

—

(3027944) Amphetamines [Presence] in Urine

276

2.17

7.11

6.8

1.6

—

(3027974) Hepatitis B virus e Ag [Presence] in Serum

12.06

7.08

1.4

1.0

—

(3008116) Ketones [Moles/volume] in Urine by Test strip

4.39

6.96

1.3

—

(40761536) Microorganisms panel - Urine sediment

207

1415

1.52

6.93

5.0

3.9

—

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

245

1735

1.47

6.89

2.7

2.4

11.18

7.56

ug/l

0.76

223

1551

(3041096) Erythrocytes [Presence] in Urine by Automated

528

4252

1.33

6.88

4.9

3.5

—

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

300

2.10

6.87

1.2

1.1

—

(3016750) Collection duration of Urine

114

2.84

6.85

2.2

2.0

477.05

483.86

min

0.11

(3011648) Oxygen content in Venous blood

162

2.50

6.69

1.5

2.7

8.40

11.28

3.70

162

(3032057) Clostridioides difficile [Presence] in Stool

4.17

6.55

2.0

—

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

147

942

1.60

6.55

2.4

—

(3001850) Coagulation factor XI activity actual/normal in Platelet poor plasma by Coagulation assay

6.56

6.33

1.2

1.1

87.38

80.11

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

169

2.39

6.14

1.7

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

169

2.39

6.14

1.7

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

169

2.39

6.14

1.7

—

(3044242) Glucose [Moles/volume] in Arterial blood

105

2.79

6.06

1.7

2.4

—

(3024891) Influenza virus A+B Ag [Presence] in Specimen

400

1.88

6.04

1.3

1.2

—

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

269

2.07

5.96

1.5

—

(3002348) Coagulation factor XII activity actual/normal in Platelet poor plasma by Coagulation assay

6.40

5.86

1.2

1.1

78.00

73.88

—

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

119

2.63

5.81

1.2

1.3

—

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

125

2.59

5.80

1.3

1.5

—

(3047189) Immunofixation for 24 hour Urine

2.88

5.78

1.1

1.8

—

(40763470) Parainfluenza virus 4 RNA [Presence] in Isolate by NAA with probe detection

213

2.19

5.74

1.6

1.5

—

(40763324) Parainfluenza virus 1 RNA [Presence] in Isolate by NAA with probe detection

213

2.19

5.74

1.6

1.5

—

(3043870) Heparin induced platelet Ab [Units/volume] in Serum

5.59

5.68

1.1

1.2

—

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

104

2.72

5.60

3.4

3.7

—

(3017704) Immunofixation for Urine

122

2.56

5.55

1.2

1.7

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

2.79

5.47

1.9

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

2.79

5.47

1.9

—

(3039443) Prostate specific Ag panel - Serum or Plasma

474

0.31

5.39

1.3

1.6

—

(3028433) Virus identified in Specimen by Culture

3.30

5.30

1.3

1.2

—

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

1569

16529

0.77

5.23

6.0

4.7

4.01

4.54

mmol/l

67.61

1467

15218

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

209

2.13

5.19

1.8

1.7

—

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

243

2.04

5.17

1.6

1.2

3.67

5.48

u/ml

0.50

114

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

191

2.17

5.08

1.8

1.7

—

(3000330) Specific gravity of Urine by Test strip

134

894

1.53

5.06

5.6

3.6

—

(3019977) pH of Arterial blood

104

2.62

5.06

3.8

2.8

7.42

0.10

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

105

2.59

4.97

1.4

1.6

—

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

105

2.59

4.97

1.4

1.6

—

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

2.68

4.91

3.3

3.9

—

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

6.03

4.91

2.2

2.3

—

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

304

1.90

4.91

1.2

1.4

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

468

1.72

4.83

1.2

1.1

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

114

1705

0.65

4.82

1.5

—

(21494815) CD4 cells/100 lymphocytes in Specimen

138

2.34

4.76

1.8

2.2

39.11

36.11

0.45

138

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

1559

16396

0.79

4.76

5.9

4.7

1.22

1.42

mmol/l

61.84

1438

14983

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

251

1.98

4.75

1.6

1.2

2.69

3.01

u/ml

0.10

(3015616) Isopropanol [Moles/volume] in Serum or Plasma

5.74

4.75

1.0

1.1

—

mmol/l

—

(3008402) Methanol [Moles/volume] in Serum or Plasma

5.74

4.75

1.0

1.1

—

mmol/l

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

463

1.71

4.74

1.2

1.1

—

(42529406) Shigella sp [Presence] in Stool by Culture

471

1.70

4.73

1.2

1.1

—

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

145

2.30

4.71

1.7

2.0

1.40

1.83

u/field

0.27

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

198

2.09

4.66

4.0

—

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

716

6229

1.23

4.64

5.5

4.0

—

(3022192) Triglyceride [Mass/volume] in Serum or Plasma

3.12

4.64

3.5

2.6

—

(3026361) Erythrocytes [#/volume] in Blood

1767

18272

0.74

4.60

63.2

22.8

4.03

4.50

e12/l

149.06

1723

17699

(3018291) Platelet Ab [Presence] in Serum

14.04

4.57

1.0

—

(3035941) MCH [Entitic mass]

1767

18270

0.74

4.57

63.0

22.7

30.88

30.46

10.87

1748

17964

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

110

2.47

4.55

2.4

2.3

—

(3010813) Leukocytes [#/volume] in Blood

1768

18272

0.74

4.47

63.2

22.8

6.58

6.78

e9/l

1.67

1727

17705

(3024731) MCV [Entitic volume]

1768

18270

0.74

4.44

63.0

22.7

93.14

91.41

28.71

1749

17967

(3009542) Hematocrit [Volume Fraction] of Blood

1767

18258

0.75

4.39

64.3

23.0

36.14

40.26

99.82

1670

16989

(3000963) Hemoglobin [Mass/volume] in Blood

1769

18275

0.75

4.38

63.8

22.9

121.37

136.16

g/l

174.88

1753

17964

(3007461) Platelets [#/volume] in Blood

1768

18266

0.75

4.38

63.3

22.8

171.49

243.65

e9/l

233.90

1730

17762

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

2.75

4.35

1.2

—

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

5.52

4.29

2.3

—

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

1616

16873

0.79

4.19

6.4

5.3

2.26

2.67

mmol/l

62.02

1493

15435

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

6.95

4.16

1.1

1.5

—

(3052592) Norovirus Ag [Presence] in Stool

4.35

4.12

1.8

1.5

—

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

3.09

4.08

1.0

1.1

1482.56

1554.90

miu/ml

0.11

(3009347) Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma

8.03

4.06

1.0

1.1

—

(3045424) Erythrocytes [Presence] in Urine

274

1.85

4.02

1.6

1.4

—

(3042517) Benzodiazepines panel - Urine

10.03

4.01

4.0

1.0

—

(3004616) Nuclear Ab [Presence] in Serum

204

1.98

3.98

1.1

1.2

—

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

4.46

3.93

2.5

1.8

—

(43055246) Days in therapeutic INR range/Days INR result determined [Ratio]

3.14

3.93

3.3

7.6

43.00

76.45

—

(3029937) Albumin [Presence] in Urine by Test strip

523

4467

1.23

3.93

5.5

4.1

0.00

estimate

0.69

200

1443

(3001019) Free T4 and TSH panel - Serum or Plasma

536

0.46

3.83

1.2

1.7

—

(3014271) Vancomycin [Susceptibility]

101

2.39

3.82

4.3

2.8

—

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

6.02

3.81

1.4

1.1

—

(46235689) Lupus anticoagulant aPTT, dRVVT and PT screening panel W Reflex

166

2.07

3.81

2.8

2.3

—

(3004347) Hepatitis D virus Ab [Presence] in Serum

12.03

3.76

1.0

—

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

134

2.18

3.74

1.3

1.2

—

(3009214) Lutropin [Units/volume] in Serum or Plasma

334

1.73

3.70

1.5

1.4

13.47

8.54

u/l

0.94

270

(3026389) Candida sp identified in Specimen by Organism specific culture

205

1.92

3.59

1.6

1.4

—

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

206

1.91

3.54

1.1

—

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

2.34

3.50

1.2

1.1

—

(3026480) Teichoate Ab [Titer] in Serum

6.17

3.50

1.0

1.2

—

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

2.55

3.46

1.2

1.12

1.07

ratio

—

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

1300

12170

1.19

3.45

4.1

3.8

14.74

14.94

pmol/l

2.00

1189

10941

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

5.02

3.37

1.0

—

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

5.02

3.37

1.6

1.4

—

(3039000) Anion gap in Blood

446

1.59

3.33

10.8

8.1

12.08

11.34

mmol/l

0.74

395

(3018572) Chloride [Moles/volume] in Blood

446

1.59

3.33

10.8

8.1

104.42

105.61

mmol/l

1.14

395

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

2.93

3.30

8.1

6.8

—

(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis

3.94

3.28

12.1

11.0

5.13

5.90

mmol/l

0.48

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

2.79

3.25

1.9

2.1

—

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

2.59

3.21

1.3

1.2

—

(3009876) Amylase isoenzyme 3 panel - Serum or Plasma

5.35

3.19

1.1

1.3

—

(3013139) Helicobacter pylori Ag [Presence] in Stool

140

1036

1.38

3.17

1.2

1.3

—

(3006653) Thiamine [Moles/volume] in Blood

2.26

3.13

1.3

125.68

144.68

nmol/l

1.18

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

735

8134

0.85

3.12

4.0

5.0

1.87

3.46

ug/l

2.00

640

7306

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

2.45

3.05

2.2

2.1

—

(3017732) Neutrophils [#/volume] in Blood

147

1104

1.36

3.04

3.6

3.4

5.99

5.28

e9/l

0.20

117

874

(3011325) HIV 1+2 Ab [Presence] in Serum

10.02

2.98

1.0

—

(3031067) HIV 1 p24 Ag [Mass/volume] in Serum or Plasma by Immunoassay

10.02

2.98

1.0

—

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

962

8849

1.17

2.96

2.8

2.5

—

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

169

1.91

2.95

1.4

1.3

—

(3020123) Porphyrins [Interpretation] in Serum or Plasma

5.40

2.87

1.3

1.0

—

(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay

5.40

2.87

1.0

1.1

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

237

1.75

2.86

2.2

1.4

—

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

3.17

2.85

1.9

1.4

—

(3037692) Legionella sp identified in Specimen by Organism specific culture

2.47

2.79

1.3

1.4

—

(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma

3.93

2.77

1.7

1.5

93.67

137.70

ng/l

—

(3002621) Streptococcal DNAse B [Units/volume] in Serum

5.01

2.73

1.0

1.1

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

226

1.74

2.71

1.0

1.1

—

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

234

1.72

2.69

1.3

1.1

—

(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma

2.34

2.65

1.3

1.2

237.71

218.69

iu/ml

0.07

(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum

2.47

2.62

1.1

—

14.56

u/ml

—

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

155

1.88

2.61

1.6

—

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

141

1.93

2.60

1.4

1.9

9299.59

1089.02

u/l

—

(3023419) Bacteria identified in Sputum by Culture

314

1.61

2.59

4.0

2.6

—

(3023919) Lactate dehydrogenase 2/Lactate dehydrogenase.total in Serum or Plasma by Electrophoresis

5.47

2.54

1.0

1.1

35.57

37.84

—

(3007858) Lactate dehydrogenase 3/Lactate dehydrogenase.total in Serum or Plasma by Electrophoresis

5.47

2.54

1.0

1.1

22.07

22.17

—

(3024830) Lactate dehydrogenase 4/Lactate dehydrogenase.total in Serum or Plasma by Electrophoresis

5.47

2.54

1.0

1.1

9.32

8.62

—

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

2.23

2.54

1.0

1.1

—

(3004716) Salmonella sp identified in Stool by Organism specific culture

670

1.41

2.52

1.3

—

(3005322) IgE [Units/volume] in Serum or Plasma

117

876

1.36

2.51

1.3

276.17

238.28

u/ml

0.28

112

802

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

503

1.47

2.51

1.3

1.4

—

(40766048) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum by Immunoassay

129

1.95

2.50

1.0

1.1

—

5.60

—

(3014891) Appearance of Pleural fluid

3.47

2.48

1.8

1.2

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

102

2.07

2.47

1.2

—

(3038071) Oxygen [Partial pressure] in Mixed venous blood

2.68

2.45

8.3

6.8

—

(3034426) Prothrombin time (PT)

2.47

2.45

1.7

1.3

—

(3049717) Cytology report of Urine Cyto stain

110

821

1.36

2.42

2.8

2.7

—

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

103

2.05

2.41

1.2

—

(3051593) INR in Capillary blood by Coagulation assay

2.15

2.35

7.2

12.8

—

(3003329) Lymphocytes/100 leukocytes in Synovial fluid

163

1.79

2.27

1.3

1.4

21.00

27.08

0.34

101

(3022621) pH of Urine by Test strip

140

1096

1.30

2.24

3.3

2.9

—

(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid

217

1.67

2.22

1.3

1.6

74.63

61.96

1.17

139

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

2.20

2.21

2.4

2.1

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

2.20

2.21

2.4

2.1

—

(3002385) Erythrocyte distribution width [Ratio]

1473

14134

1.15

2.20

52.0

18.3

16.41

15.18

14.97

1463

13859

(3008536) Aspergillus sp Ab [Presence] in Serum

2.51

2.18

1.2

1.7

—

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

3.34

2.18

1.1

1.5

—

(40768800) Prostate Pathology biopsy report

522

0.61

2.12

1.2

—

(21494814) CD8 cells/100 lymphocytes in Specimen

2.21

2.11

1.9

2.1

—

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

1552

14966

1.16

2.10

5.2

4.5

2.31

2.06

mu/l

2.03

1447

13515

(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum

138

1.82

2.09

1.0

1.1

98.20

34.20

u/ml

—

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

1537

15889

0.86

2.08

5.4

4.2

1.41

1.32

mmol/l

4.60

1422

14399

(3022689) Creatine [Moles/volume] in Urine

2.57

2.08

2.6

1.6

—

(3044941) Cell count panel - Synovial fluid

293

1.55

2.06

1.3

1.4

—

(3011335) Digoxin [Mass/volume] in Serum or Plasma

3.51

2.05

2.4

3.3

—

(3013293) Extractable nuclear Ab [Presence] in Serum

3.51

2.05

1.1

1.6

—

(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay

184

1.70

2.04

1.4

1.1

86.23

96.01

1.40

175

(3045683) HLA typing for celiac disease panel - Blood or Tissue

2.15

1.98

1.1

1.0

—

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

3.34

1.96

1.1

—

(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood

112

1.88

1.96

2.5

2.7

33.69

39.69

—

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

1.95

1.4

1.2

—

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

2.57

1.94

1.0

1.4

—

(3051387) C reactive protein [Mass/volume] in Capillary blood

380

1.46

1.93

4.9

3.5

28.18

27.61

mg/l

0.03

241

(1002224) Polysomnography panel

613

0.66

1.88

1.1

—

(3013637) Mi-2 Ab [Presence] in Serum

2.40

1.85

1.1

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

2.40

1.85

1.1

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

2.40

1.85

1.1

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

2.40

1.85

1.1

—

(3042891) Cardiolipin IgM Ab [Mass/volume] in Serum

3.54

1.84

1.5

1.1

—

(3004446) Plasmodium sp identified in Blood by Light microscopy

4.17

1.82

2.4

2.7

—

(40765096) Chromosome analysis panel by Banding

2.06

1.80

1.1

—

(3021788) Differential panel - Synovial fluid

337

1.47

1.78

1.3

1.6

—

(3045414) Leukocytes [Presence] in Urine

740

1.31

1.77

2.2

1.8

—

(4094501) Cardiovascular stress test using bicycle ergometer

532

0.65

1.76

1.2

1.1

—

(3017446) Testosterone [Moles/volume] in Serum or Plasma

126

1562

0.79

1.75

2.2

12.35

13.09

nmol/l

0.38

113

1381

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

1.94

1.75

1.3

—

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

3.34

1.74

1.0

1.1

—

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

1596

16395

0.87

1.68

6.3

4.9

6.89

6.05

mmol/l

44.83

1484

14818

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

3.16

1.66

1.0

1.2

—

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

1619

15740

1.14

1.64

10.8

6.1

44.40

40.45

mmol/mol

25.77

1536

14497

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

105

1.82

1.63

1.9

1.8

—

(3035320) C reactive protein [Mass/volume] in Body fluid

105

1.82

1.63

3.1

2.4

—

(3000034) Microalbumin [Mass/volume] in Urine

174

1.62

1.61

5.8

3.1

75.92

34.71

mg/l

0.52

138

(3003327) Ova and parasites identified in Stool by Light microscopy

456

1.37

1.59

1.5

1.7

—

(3001964) Herpes simplex virus Ag [Presence] in Specimen

2.21

1.57

1.3

1.4

—

(3025130) Human papilloma virus identified in Specimen

1.86

1.56

2.5

1.8

—

(3051101) Glucose [Moles/volume] in Cord blood

2.43

1.53

17.2

6.0

—

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

2.43

1.53

1.0

1.1

—

(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

3.34

1.52

1.0

—

(3044889) 12 lead EKG panel

1277

12274

1.11

1.48

5.0

4.1

—

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

102

1.77

1.45

1.1

—

(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method

2.73

1.43

1.0

—

(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis

2.18

1.40

1.1

1.7

13.34

14.48

pmol/l

—

(40757373) Influenza virus identified in Isolate

2.18

1.40

1.3

1.6

—

(3008898) HLA-B27 [Presence]

445

0.67

1.39

1.1

—

(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum

2.42

1.39

1.0

1.2

—

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

2.42

1.39

1.0

1.2

—

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

2.01

1.38

1.2

1.1

—

(3000475) Leukocytes [#/volume] in Synovial fluid

445

1.34

1.33

1.4

1.6

18366.68

15342.16

e6/l

0.19

321

(40761535) Cells panel - Urine sediment

179

1535

1.18

1.33

4.4

3.4

—

(3006442) Creatine [Moles/volume] in Serum or Plasma

121

1.66

1.30

1.5

100.45

87.67

umol/l

0.70

121

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

2.36

1.29

28.2

1.9

—

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood

2.29

1.27

7.1

7.7

—

(3001686) Cold agglutinin [Titer] in Serum or Plasma

2.29

1.27

1.3

—

159.14

—

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

2.29

1.27

1.1

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

129

1533

0.83

1.26

1.4

—

(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma

2.64

1.21

1.8

1.4

10.40

16.63

u/l

—

(3006270) Folate [Moles/volume] in Blood

141

1.57

1.17

1.4

1.2

273.67

361.70

nmol/l

1.12

121

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

2.50

1.15

2.6

2.9

0.60

0.40

u/field

—

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

118

1.62

1.15

2.9

1.1

—

(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification

1.69

1.13

8.2

6.4

183.00

46.15

u/ml

—

(3019150) Specific gravity of Urine by Refractometry

393

3607

1.11

1.10

5.6

4.1

1.02

kg/l

0.03

525

(3004451) EKG impression Narrative

113

1.60

1.05

1.2

1.3

—

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

2.13

1.05

1.3

1.1

—

(3028679) Herpes simplex virus Ab [Presence] in Serum

1.81

0.98

1.1

—

(3033923) Metanephrine [Moles/time] in 24 hour Urine

1.95

0.97

1.3

1.1

—

0.74

—

(40768793) Breast Pathology biopsy report

295

0.67

0.97

1.3

—

(3019832) Treponema pallidum Ab [Presence] in Serum

651

1.22

0.95

1.6

1.5

—

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

234

1.37

0.93

3.2

2.3

14.90

23.83

mg/l

—

(3024263) Appearance of Synovial fluid

101

1.59

0.93

1.2

1.4

—

(3010838) Calcium [Moles/time] in 24 hour Urine

295

1.33

0.93

1.6

2.0

5.19

4.91

mmol/24h

0.12

258

(3002079) Sodium [Moles/time] in 24 hour Urine

1.72

0.92

1.1

1.3

142.25

176.60

mmol/24h

0.61

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

2.15

0.91

1.0

1.2

—

(3044290) Cell count panel - Cerebral spinal fluid

341

1.30

0.89

1.5

1.3

—

(3000285) Sodium [Moles/volume] in Blood

2.07

0.89

1.2

1.0

—

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

1.79

0.87

1.3

1.1

—

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

144

1.46

0.87

1.0

1.2

—

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

284

2601

1.11

0.85

1.3

43.49

35.31

iu/ml

0.46

840

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

1.94

0.84

1.3

2.0

—

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

1.65

0.81

1.1

1.2

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

260

0.69

0.81

1.3

1.5

—

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

0.00

0.79

0.0

1.1

—

(3020564) Creatinine [Moles/volume] in Serum or Plasma

1750

17723

0.91

0.79

50.5

18.3

94.28

81.75

umol/l

16.97

1750

17714

(40758292) HTLV I+II Ab panel - Serum

1.77

0.76

1.0

1.4

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

1.70

0.75

5.4

2.3

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

1.70

0.75

5.4

2.3

—

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

1.70

0.75

1.2

2.3

—

(3010144) Erythrocytes [#/volume] in Synovial fluid

176

1.37

0.72

1.1

1.3

27845.57

71006.38

e6/l

0.54

123

(1617658) Protocol used for examination of sentinel lymph nodes

110

0.54

0.72

1.0

—

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

194

1.34

0.71

1.4

1.3

—

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

1.75

0.71

1.0

1.1

—

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

212

2318

0.90

0.70

16.5

7.4

—

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

1.55

0.69

1.0

1.1

—

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

178

1.35

0.68

1.0

1.1

2.70

2.18

u/ml

—

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.85

0.68

1.0

—

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

392

1.23

0.68

1.4

1.3

—

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

1.59

0.65

1.0

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

796

0.85

0.65

1.5

1.6

—

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

1.73

0.64

1.0

1.1

—

(3023323) Follitropin [Units/volume] in Serum or Plasma

318

1.23

0.58

1.4

27.48

29.51

iu/l

0.14

266

(3038769) Chlamydophila pneumoniae IgG Ab [Units/volume] in Serum by Immunoassay

0.00

0.58

0.0

1.0

—

48.52

—

(3000213) Normetanephrine [Moles/time] in 24 hour Urine

0.00

0.58

0.0

1.2

—

1.98

—

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

392

1.20

0.57

1.2

1.1

—

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

441

0.81

0.57

1.5

1.7

—

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

0.56

1.2

1.1

—

(3019550) Sodium [Moles/volume] in Serum or Plasma

1764

17459

1.08

0.55

52.5

18.1

138.07

139.70

mmol/l

82.08

1745

17036

(3024869) Neuronal Ab [Presence] in Serum

1.62

0.55

1.0

1.1

—

(3023659) Complement C1 esterase inhibitor.functional/Complement C1 esterase inhibitor.total in Serum or Plasma

1.62

0.55

1.3

115.17

111.13

—

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

845

1.13

0.53

2.5

3.3

3.76

4.42

pmol/l

8.61

739

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.45

0.53

1.0

1.1

—

(3023511) Choriogonadotropin [Units/volume] in Urine

1.43

0.52

1.2

1.3

—

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

1105

0.89

0.52

2.6

2.5

34.78

23.43

au/ml

—

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

999

0.89

0.51

1.3

34.34

63.08

au/ml

—

(3005791) Eosinophil cationic protein (ECP) [Mass/volume] in Serum

1.39

0.50

1.9

19.26

142.02

ug/l

—

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

209

1.25

0.46

1.1

—

(3026179) Normetanephrine [Moles/volume] in Serum or Plasma

210

1.24

0.45

1.3

0.78

0.63

nmol/l

0.77

201

(40761511) CBC panel - Blood by Automated count

1696

17120

0.94

0.44

40.3

14.7

—

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

184

1.25

0.43

1.4

1.3

—

nmol/l

—

(3016018) Differential panel - Cerebral spinal fluid

175

1.26

0.43

1.1

1.4

—

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

1.61

0.43

3.2

1.5

—

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

1.38

0.41

1.5

1.1

—

(40766799) MGMT gene methylation score in Tissue by Molecular genetics method

0.00

0.41

0.0

1.0

—

(4034850) Laboratory test

552

1.13

0.38

18.6

10.0

—

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

1.35

0.37

1.0

1.2

—

(3033306) Mononuclear cells/100 leukocytes in Cerebral spinal fluid

1.39

0.37

2.5

1.2

—

68.00

—

(3023103) Potassium [Moles/volume] in Serum or Plasma

1764

17508

1.06

0.36

52.7

18.3

4.02

3.99

mmol/l

2.82

1745

17056

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

475

4591

1.05

0.36

2.0

1.7

1.53

1.39

mmol/l

2.27

422

3785

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

1758

17706

0.95

0.36

30.1

10.9

39.13

26.86

u/l

21.20

1739

17044

(3025018) Bordetella pertussis Ab [Titer] in Serum

0.62

0.35

1.4

1.3

—

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

1.40

0.35

1.0

1.2

—

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

1.40

0.35

1.0

1.3

—

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

1.32

0.33

1.1

—

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

1.32

0.33

1.8

1.6

—

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

0.70

0.33

1.7

1.5

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

306

0.85

0.32

1.5

1.3

—

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

848

1.09

0.32

1.2

134.31

154.35

iu/ml

0.16

310

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.27

0.30

1.0

1.1

—

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

1.25

0.29

1.0

1.1

—

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

1.23

0.29

1.0

1.1

—

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

110

0.73

0.29

1.1

1.0

—

(4200892) Spirometry reversibility

136

1281

1.07

0.28

1.4

—

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

1.29

0.28

1.0

1.1

—

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

1597

15845

1.04

0.27

39.9

14.6

74.12

77.59

ml/min/173m2

6.06

1443

13112

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

719

0.92

0.27

1.4

1.6

—

(3003338) MCHC [Mass/volume]

1344

13569

0.97

0.24

55.6

20.4

330.76

332.68

g/l

8.86

1333

13464

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

0.71

0.24

1.0

1.1

—

8.19

—

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

199

1.16

0.23

1.0

1.1

6.70

2.33

u/ml

0.43

106

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

208

2000

1.04

0.22

1.4

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

0.74

0.22

1.0

1.2

—

(3017509) Phencyclidine [Presence] in Urine

0.00

0.21

0.0

1.4

—

(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture

0.00

0.21

0.0

1.2

—

(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum

0.00

0.21

0.0

1.0

—

(3022475) Manganese [Moles/volume] in Blood

0.00

0.21

0.0

1.3

—

(40761995) Spermatozoa Progressive [#/volume] in Semen

0.00

0.21

0.0

3.3

—

(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen

0.00

0.21

0.0

6.6

—

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

1.23

0.21

2.0

1.5

—

(3020911) Cortisol [Moles/time] in 24 hour Urine

1.16

0.21

1.2

1.7

75.60

236.19

nmol/24h

—

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

231

2234

1.04

0.20

5.1

4.7

31.12

32.38

0.95

188

1480

(3026470) Cobalt [Mass/volume] in Blood

133

0.83

0.19

1.6

2.1

16.82

3.35

ug/l

0.56

121

(3003888) Timothy IgE Ab [Units/volume] in Serum

175

1.14

0.18

1.1

4.61

4.76

u/ml

0.02

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

162

0.86

0.16

1.1

1.0

—

(3003740) Influenza virus B Ag [Presence] in Specimen

187

1.12

0.15

1.0

1.1

—

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

341

1.09

0.15

1.2

1.8

4.55

4.89

iu/l

0.06

108

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

0.77

0.15

1.0

—

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

121

1.16

0.15

1.4

1.3

2.21

1.07

u/ml

—

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

192

0.88

0.14

1.1

1.3

10.88

7.51

mmol/l

1.84

169

(3002523) Influenza virus A Ag [Presence] in Specimen

188

1.12

0.14

1.0

1.1

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

676

0.95

0.14

1.1

1.0

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

899

0.95

0.14

1.2

1.3

—

(3023430) Cat dander IgE Ab [Units/volume] in Serum

122

1.15

0.13

1.1

0.97

2.98

u/ml

—

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

434

1.06

0.12

1.4

1.2

—

(3010726) Horse dander IgE Ab [Units/volume] in Serum

162

1.11

0.11

1.1

0.44

1.59

u/ml

1.16

(3005570) Glucose [Moles/volume] in Urine

182

1.10

0.11

2.0

2.1

—

(3030862) Granulocytes [#/volume] in Cerebral spinal fluid

1.06

0.09

1.0

1.2

—

10.88

—

(3009466) Valproate [Moles/volume] in Serum or Plasma

237

0.93

0.09

3.3

4.8

331.53

353.85

umol/l

0.39

211

(3008832) Norclozapine [Moles/volume] in Serum or Plasma

0.86

0.07

18.6

10.7

882.14

823.84

nmol/l

—

(3019420) Tryptase [Mass/volume] in Serum or Plasma

0.87

0.07

1.4

1.5

15.41

8.78

ug/l

—

(3047007) Chlamydophila sp Ab [Presence] in Serum

206

1.07

0.07

1.2

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

212

0.94

0.05

1.9

1.8

—

(3023410) Appearance of Cerebral spinal fluid

170

1.06

0.04

1.4

1.5

—

(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum

230

0.96

0.03

1.2

1.1

—

13.44

—

(3032773) Endomysium IgG Ab [Titer] in Serum

128

0.94

0.02

1.2

1.0

—

titre

—

(3014051) Protein [Presence] in Urine by Test strip

450

0.98

0.02

3.0

2.5

—

(3008401) Mugwort IgE Ab [Units/volume] in Serum

172

1.05

0.02

1.1

1.36

1.72

u/ml

—

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

372

1.02

0.01

1.6

1.4

9.14

33.37

e6/l

0.74

286

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

372

1.02

0.01

1.7

1.4

169.75

810.44

e6/l

1.06

299

(40768795) Lymph node Pathology biopsy report

163

1.04

0.01

1.4

1.2

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

267

0.97

0.01

1.8

—

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

251

2502

1.00

0.01

1.3

1.2

15.25

13.44

u/ml

0.12

942

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

265

1.02

0.00

1.1

—

(40758358) Immune stain study

0.00

0.0

1.0

—

(3025886) Oxalate [Mass/time] in 24 hour Urine

0.00

0.0

1.0

—

(3008799) Glucose [Moles/volume] in Serum or Plasma --30 minutes post dose glucose

0.00

0.0

1.1

—

7.67

—

(3011048) Pyruvate [Moles/volume] in Blood

0.00

0.0

1.3

—

91.00

—

(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay

0.00

0.0

1.0

—

(3017312) HC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

0.00

0.0

1.0

—

(3006044) Creatine kinase.total/Creatine kinase.MB [Enzymatic activity ratio] in Serum or Plasma

0.00

0.0

1.3

—

2.56

—

(3027401) Testosterone Free/Testosterone.total in Serum or Plasma

0.00

-0.00

0.0

1.9

—

1.31

—

(3037441) Creatinine [Moles/volume] in Peritoneal dialysis fluid

0.00

-0.00

0.0

5.0

—

382.00

—

(40760410) HLA-B [Type] by High resolution

0.00

-0.00

0.0

1.0

—

(3014114) Aureobasidium pullulans IgG Ab [Mass/volume] in Serum

0.00

-0.00

0.0

1.0

—

(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid

180

1.00

-0.00

1.1

—

(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain

0.00

-0.00

0.0

1.5

—

(3033093) Yersinia sp IgM Ab [Titer] in Serum

0.00

-0.00

0.0

2.0

—

(3039817) Yersinia enterocolitica IgA Ab [Presence] in Serum

0.00

-0.00

0.0

2.0

—

(3038714) Yersinia pseudotuberculosis Ab [Titer] in Serum by Agglutination

0.00

-0.00

0.0

1.0

—

(40763590) HLA-DQ beta [Type]

0.00

-0.00

0.0

1.0

—

(3012989) Citrate [Moles/time] in 24 hour Urine

0.00

-0.00

0.0

1.4

—

2.17

—

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

0.00

-0.00

0.0

1.3

—

(40760409) HLA-A [Type] by High resolution

0.00

-0.00

0.0

1.0

—

(3042301) Urate [Moles/volume] in Synovial fluid

0.00

-0.00

0.0

1.0

—

(3041184) Isoniazid [Presence] in Urine

0.00

-0.00

0.0

1.2

—

(3040944) Yersinia pseudotuberculosis 3 Ab [Titer] in Serum

0.00

-0.00

0.0

1.0

—

(3020356) Listeria sp identified in Specimen by Organism specific culture

0.00

-0.00

0.0

1.0

—

(46236302) HLA-C [Type] by High resolution typing

0.00

-0.00

0.0

1.0

—

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

0.87

-0.00

1.3

1.6

—

(3018688) Ampicillin IgE Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.0

—

(46236344) Yersinia enterocolitica O:9 IgG Ab [Presence] in Serum by Agglutination

0.00

-0.00

0.0

1.0

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

1.00

-0.00

1.3

1.2

—

(3015183) Erythrocyte sedimentation rate

0.98

-0.00

1.0

1.2

—

(3045519) Venlafaxine [Moles/volume] in Serum or Plasma

0.00

-0.00

0.0

1.2

—

569.74

—

(44813793) Dust mix specific IgE antibody measurement

0.93

-0.00

1.1

1.0

—

(3012565) Volume of 24 hour Urine

0.98

-0.00

2.1

3.0

1938.89

1827.08

—

(3013862) HLA-DP [Type]

0.00

-0.00

0.0

1.0

—

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

110

1.00

-0.00

1.0

1.1

1.40

0.28

u/ml

—

(3042341) Yersinia pseudotuberculosis Ab [Presence] in Serum

0.00

-0.00

0.0

2.0

—

(3038864) risperiDONE [Moles/volume] in Serum or Plasma

0.00

-0.00

0.0

1.0

—

7.37

—

Mortality – FinRegistry

↥

Association

Association between endpoint CHIRHEP_NAS and mortality.

Females

Parameter	HR [95% CI]	p-value
CHIRHEP_NAS	8.169 [6.82, 9.79]	< 0.001
Birth year	1.0 [0.99, 1.01]	0.963

During the follow-up period (1.1.1998 — 31.12.2019), 2224 out of 3896 females with CHIRHEP_NAS died.

Males

Parameter	HR [95% CI]	p-value
CHIRHEP_NAS	9.397 [7.67, 11.51]	< 0.001
Birth year	0.986 [0.98, 1.0]	0.003

During the follow-up period (1.1.1998 — 31.12.2019), 3499 out of 5661 males with CHIRHEP_NAS died.

Mortality risk

Mortality risk for people of age

years, who have CHIRHEP_NAS.

N-year risk	Females	Males
1	1.008%	1.497%
5	5.56%	9.387%
10	12.789%	23.294%
15	24.546%	38.804%
20	39.066%	57.792%

Relationships between endpoints

↥

Index endpoint: CHIRHEP_NAS – Cirrhosis of liver, NAS

GWS hits: 5

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

rg [CI]

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Cirrhosis of liver, NAS

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints